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ABSTRACT 
PREDICTING OUTCOME AT POSTTREATMENT FOR ADOLESCENT OBSESSIVE-COMPULSIVE 
DISORDER IN A RESIDENTIAL TREATMENT SETTING 
 
by 
 
Heather M. Jones 
 
The University of Wisconsin-Milwaukee, 2014 
Under the Supervision of Professor Karen Callan Stoiber 
 
Exposure and response prevention (ERP) paired with psychopharmacological interventions are 
considered first line treatments for pediatric obsessive compulsive disorder (OCD).  Recent 
literature has emphasized the importance of investigating effectiveness and treatment 
outcomes for difficult-to-treat cases of pediatric OCD who do not respond to outpatient 
treatment.  Effectiveness studies have found that adolescent patients treated in residential 
settings have demonstrated gains comparable to those patients included in published 
outpatient outcomes studies (Bjorgvinsson et al., 2008; Leonard et al., 2014).  Current research 
efforts are needed to 1) better predict gains in real-world clinical settings and 2) identify risk 
factors for difficult-to-treat patients who have previously failed effective treatment strategies.  
The purpose of this study was to investigate predictors of residential treatment outcome in 196 
adolescent (13-17 years old) patients receiving intensive combined treatment for a primary 
diagnosis of OCD.  Clinical factors within five relevant domains were investigated to determine 
whether predictors above and beyond baseline symptom severity are able to predict OCD 
treatment response in this population. Patients were assessed at admission and discharge with 
standardized self-report measures of OCD symptom severity, depression, anxiety sensitivity, and 
anxiety-related symptoms.   Admission data were used for the prediction of OCD severity at 
discharge as measured by the Children’s Yale-Brown Obsessive-Compulsive Scale – Self Report 
 iii 
 
(CY-BOCS-SR; Piacentini, Langley, & Roblek, 2007).  Results indicated the variables of having 
received partial hospitalization/day treatment prior to admission to residential and higher 
severity at admission significantly predicted greater OCD severity at discharge. The relation 
between treatment history and outcome deserve additional exploration to uncover factors 
related to previous treatment experience and subsequent treatment outcomes.  Differences 
among subtests on the CY-BOCS-SR in predicting treatment outcome provided evidence for the 
need for additional investigations of the link between severity of compulsory behaviors at 
admission and response to treatment.   The challenge remains to systematically identify 
program components that match unique patient needs to increase prescriptive efficacy with this 
difficult-to-treat population. 
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CHAPTER 1: Introduction 
 Obsessive compulsive disorder (OCD) is a pervasive mental disorder that significantly 
impacts one’s family, social, and work or school functioning.  According to the Diagnostic and 
Statistical Manual of Mental Disorders, Fifth Edition (DSM-5, American Psychiatric Association, 
2013), the diagnostic criteria for obsessive-compulsive disorder are recurrent obsessions and 
compulsions that significantly impact an individual’s functioning.  Obsessions are defined as 
“recurrent and persistent thoughts, urges, or images that are experienced, at some time during 
the disturbance, as intrusive and unwanted, and that in most individuals cause marked anxiety 
or distress” (APA, 2013, p. 237).  Compulsions are defined as “repetitive behaviors or mental 
acts that the individual feels driven to perform in response to an obsession or according to rules 
that must be applied rigidly” (APA, 2013, p.237).  The functional relationship between 
obsessions and compulsions has received considerable empirical support (Rachman & Hodgson, 
1980).  Kozak and Foa (1996) describe obsessions as thoughts, images, or impulses that generate 
anxiety while compulsions are overt (behavioral) or covert (mental) actions that are performed 
to temporarily and artificially reduce the anxiety produced by the obsession.   
Historically, the lifetime prevalence of this disorder has been reported to impact 
between 2-3% of the population and between 1-3% children and adolescents (Flament et al., 
1988; Valleni-Basile et al., 1995). More recent reports estimate twelve-month prevalence rates 
to be 1.2% in adult outpatient settings (Ruscio, Stein, Chiu, & Kessler, 2010) with similar 
prevalence rates in primary care settings (Veldhuis et al., 2012).  Recent studies have estimated 
prevalence rates among children and adolescents to vary from 2 to 4% (Merlo, Storch, Adkins, 
Murphy, & Greffken, 2007).  A large number of adult OCD patients have their first onset in late 
childhood or adolescence.  Rasmussen and Eisen (1990) found that OCD symptoms persist in 
50% of adults who first developed symptoms during childhood or adolescence with a range of 
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age of onset between 13-24 years.  It is suggested that OCD follows a bimodal distribution of 
incidence in childhood and adulthood with a 3 to 2 ratio of male to female occurrences in 
childhood, which equally distribute between genders by adolescence.  It is not uncommon for 
people to suffer for several years with OCD prior to seeking treatment.  Rasmussen and Tsuang 
(1986) found that on average most individuals presented for treatment 7 years after first 
experiencing symptoms.  Thus, besides reducing morbidity and functional impairment in 
pediatric OCD, empirically supported treatments have the potential to reduce OCD symptoms 
and related dysfunction in adulthood.   
Treatment of OCD 
Exposure response prevention (ERP), a behavioral component of cognitive behavioral 
therapy (CBT), paired with psychopharmacological interventions is considered first line 
treatment for adult and pediatric obsessive compulsive disorder (OCD).  The efficaciousness of 
CBT, pharmacotherapy, and both in combination have been well documented for both adult and 
pediatric OCD (O’Connor et al., 2006; Eddy, Dutra, Bradley, & Westen, 2004).  Often, pediatric 
patients with OCD receive pharmacological interventions first before behavioral interventions 
are added.  It is hypothesized that this may be because patients and families find ERP “too 
difficult” or once in treatment find the initial distress so aversive, they discontinue (Franklin, 
Freeman, & March, 2010).  It is worth noting, however, that clinical trials point out important 
limitations to the effectiveness of pharmacologic interventions alone.  These limitations include: 
variability in the efficacy of pharmacological intervention across individuals, medications side 
effects, and poor maintenance of gains on medications alone (Kozak, Liebowitz, & Foa, 2000).  
CBT has received the highest degree of empirical support and is considered the treatment of 
choice for children, adolescents, and adults with OCD even when pharmacological interventions 
are unavailable.       
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ERP is based on the principle that anxiety decreases over time when an individual is in 
contact with a feared stimulus that is not innately dangerous.  Learning theory has identified this 
process and termed it ‘extinction’ – the gradual discontinuation of a behavior when 
reinforcement no longer follows a behavior (operant conditioning) or when a conditioned 
stimulus is presented alone without the unconditioned stimulus (classical conditioning).  For 
example, a patient with an irrational fear of germs will confront anxiety-producing but 
objectively low-risk situations (i.e. holding a commonly used door knob) that allow his or her 
anxiety to decrease naturally over time, a process referred to as habituation within the context 
of ERP.  Successful exposure trials depend on the patient’s ability to block the negative 
reinforcement effect of rituals/compulsions or other avoidance - this process is referred to as 
ritual prevention.  Disengaging from rituals thus removes the negative reinforcement resulting 
from the compulsion.  ERP utilizes components of operant conditioning (approaching, not 
avoiding aversive stimuli) as well as classical conditioning (presenting a conditioned stimulus 
repeatedly until the anxiety response has been eliminated).    
Patients often have a range of feared stimuli starting with those items or situations that 
cause little or no anxiety, those that are tolerable, and those items that will almost certainly 
induce a state of panic.  In treatment, patients develop an exposure hierarchy, which is a list of 
all feared stimuli.  This list is comprehensive but not exhaustive as the purpose of ERP is to 
produce generalization overtime.  As part of the hierarchy development, patients are asked to 
rate their anxiety on a Subjective Units of Distress Scale (SUDS; Wolpe, 1969) with 0 = no anxiety 
and 100 = panic.  Exposures that patients subjectively anticipate causing little anxiety are rated 
lower on the scale and placed further down in the hierarchy while panic-inducing items are 
placed at the top.  Once the hierarchy is developed, therapists begin to help repeatedly “expose” 
patient to feared stimuli while the patient is expected to refrain from engaging in rituals in order 
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to produce habituation to the feared stimuli.   Patients are asked to complete the same 
exposure repeatedly to achieve both within- and between-trial habituation (Grayson, Foa, & 
Steketee, 1986).  Each exposure is continued until the patient’s anxiety has reduced by half 
(within-trial habituation).  Over time, each successive trial will produce less anxiety (between-
trial habituation).  During treatment, the percentage of completed exposures on the hierarchy is 
used to measure the patient’s progress. Alternatively, a rate of habituation can be calculated.  
Though ERP emphasizes the behavioral components within the CBT treatment, the 
cognitive components of CBT serve as a binder that brings together aspects of ERP and teaches 
useful tools for managing anxiety and obsessions.  These include: (1) active thought challenging 
of irrational OCD thoughts, (2) disassociation or separation of the individual and the disorder, 
and (3) “cultivating nonattachment” or learning to allow obsessional thoughts to come without 
acting on them or engaging in mental neutralization of the anxiety (Franklin, Freeman, & March, 
2010, p. 82).  It has been common practice for clinicians to implement cognitive-only 
interventions for OCD prior to initiating behaviorally-based interventions (Deacon, & Nelson, 
2008).  This technique is used to identify feared stimuli, determine the level of insight to the 
rationality of obsessions, and to start to challenge pathological beliefs.  Challenging these 
pathological beliefs is often difficult for patients due to the cyclical nature of OCD (i.e., obsession  
 anxiety   compulsion  elimination of anxiety).   The elimination of anxiety serves as 
negative reinforcement for the continued use of compulsions which increases severity of OCD 
symptoms.  Positive reinforcement when offered alone has found to have little impact over OCD 
symptoms, but reward following exposure tasks has been found to increase ERP compliance 
which breaks the cycle of the behavioral response (compulsion) that is reinforced negatively by 
the elimination of anxiety.   Additionally, success in ERP produces a reduction of OCD symptoms 
that promotes continued engagement, generalization, and maintenance of skills gained during 
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treatment (Franklin, Freeman, & March, 2010).  More often than not both behavioral and 
cognitive components are integrated in treating OCD.  Evidence suggests however that taken 
alone, behaviorally oriented ERP with no cognitive component is able to produce both 
statistically and clinically significant reductions in OCD symptoms at treatment end and 14-week 
follow-up (Bolton, & Perrin, 2008).   
Due to the pervasive nature of OCD and cyclical nature of the disorder (e.g., engaging in 
compulsions reduces anxiety and is negatively reinforcing, leading to increased engagement in 
compulsions), it is not uncommon for individuals to develop debilitating symptoms that limit 
functionality.  As mentioned previously, demographic data suggest that individuals often wait to 
receive treatment for OCD which is problematic given its progressive nature (Rasmussen, & 
Tsuang, 1986).  Most individuals seek either outpatient treatment, which consists of 1-2 
appointments per week by a licensed therapist, or pharmacological intervention, which may 
include one 15-minute appointment with a licensed psychiatrist or meeting with their primary 
care physician. 
Statement of Problem   
There is currently a documented shortage of trained therapists utilizing first line 
treatments for OCD (i.e., ERP; Franklin, Freeman, & March, 2010). Patients who are unable to 
receive ERP are likely to experience an increase of OCD symptoms. Even individuals who have 
been receiving treatment from an outpatient therapist may experience an increase in symptoms 
due to treatment resistant or difficult-to-treat OCD.  Despite evidence demonstrating the 
effectiveness of exposure-based treatment of OCD, a meta-analysis (Abramowitz, Whiteside, & 
Deacon, 2005) found that 27% of studies measuring the effectiveness of ERP failed to show 
significant response to treatment indicating a subset of individuals that fail to respond to typical 
treatment.  Storch et al. (2008) identified the following contributors to treatment resistant OCD 
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in a group of 60 pediatric outpatients: significantly more obsessions and compulsions, more 
internalizing symptoms, family dynamics that accommodate the OCD, and a greater degree of 
functional impairment compared to those individuals who responded to outpatient treatment.   
For these individuals or for those for whom outpatient treatment is unavailable, intensive or 
residential treatment is recommended.  More intensive CBT allows clinicians to increase the 
treatment dose (i.e. the number of hours of ERP provided per week), which may be helpful for 
patients with more severe or complex presentations.   These patients may require more focused 
interventions consisting of multimodal treatments, intensive monitoring due to severe 
symptoms, and delivery of ERP at a more intensive level than outpatient providers are able to 
provide.    
With need comes the emergence of programs offering intensive treatment for pediatric 
OCD.   Residential treatment meets the needs of these patients with increased duration and 
intensity of CBT, removal from dynamics within the family setting that has accommodated 
anxiety, and staff monitoring and therapeutic support to assist with ritual prevention, assigned 
exposure completion, and other treatment goals.  While evidence from naturalistic studies 
support the benefits of CBT for pediatric OCD (Nakatani, Mataix-Cols, Micali, Turner, & Heyman, 
2009; Vande Voort, Svecova, Jacobsen, & Whiteside, 2010) and adults with OCD (Franklin, 
Abramowitz, Kozak, Levitt, & Foa, 2000; Warren & Thomas, 2001) in traditional outpatient 
settings, few studies have measured the effectiveness of intensive treatment within a residential 
setting or variables contributing to success in this setting.  Additional research is needed to 
investigate whether factors exist that can predict effectiveness of treatment within this setting 
with patients who have severe and complex mental illnesses that have not been successfully 
addressed with outpatient support.   
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Residential treatment is often considered a “last resort” for families when all other 
therapeutic interventions have been exhausted without improvement of symptoms.  The 
demographic of patients receiving residential treatment for OCD are assumed to include 
individuals with severe, refractory OCD; complex comorbidities; and previous unsuccessful 
treatment attempts (Leonard et al., 2014; Stewart, Yen, Stack, & Jenike, 2006).  Despite these 
factors, dropout rates in residential settings are low possibly due to the fact that patients are at 
“the end of the road” in terms of treatment options and patients who are minors, while needing 
to consent to treatment, receive encouragement from their parents to remain in treatment 
(Franklin, Freeman, & March, 2010).  Buy-in with pediatric patients and their families is an 
integral part of the admissions and early treatment process.  Parents want to know they are 
making a decision that is in the best interest of their child and want to have some assurance that 
the time their children are spending in treatment, away from family, friends, school, and 
“normal” teenage life, is going to be a worthwhile investment.  Since, many of the outcome 
studies investigating the treatment of pediatrics with OCD have utilized weekly therapy sessions, 
little is known about dosage of treatment for the residential patient.  Franklin et al. (1998) found 
no significant difference between 14 sessions over 12 weeks and 18 sessions over 4 weeks.  
Storch et al. (2007) provides evidence that patients respond as well to weekly sessions as they 
do to intensive (daily) doses of ERP.  Only two studies to date have evaluated the effectiveness 
of residentially-based OCD treatment for adolescents (see Bjorgvinsson et al., 2008; Leonard et 
al., 2014).  Both open-trials revealed significant decreases in OCD severity from admission to 
discharge which were maintained at follow-up, however little is known about the characteristics 
of the patients who responded to treatment versus those who did not.     
The ability to better predict post-treatment outcome from early symptoms is valuable to 
patients, their families, treatment providers, and funding sources.  It has been discussed that 
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ERP is a difficult labor-intensive and emotionally-intensive treatment; therefore, providing 
patients with evidence-based information regarding their progress could certainly provide 
incentive for continued motivation and endurance through treatment.  Similarly, patient families 
who are invested in the treatment progress can benefit from this information as they encourage 
and support their child’s progress through treatment.  Another benefit of identifying predictive 
variables to success is to better inform outpatient therapists on the factors that contribute to 
gains in residential treatment.   At face value this information might seem irrelevant, but to the 
extent an outpatient therapist could coach and prepare a patient for intensive treatment this 
information might offer evidence to future patients of what factors contribute to long-term 
gains.   To the extent that patient characteristics predict subsequent reduction in OCD 
symptoms during the course of treatment and follow-up, clinicians can use this information to 
guide treatment – either maintaining the steady course of the current treatment strategies or 
consideration of augmentation with other interventions.  Finally, with the availability of 
intensive treatment for patients with severe OCD comes the reality of funding such treatment.  
The reality exists that intensive psychiatric treatment is tremendously expensive and families 
are faced with decisions on how to fund treatment.  One study reports the average cost of 
psychiatric hospitalization has been found to be between $775 and $1000 per day (Stensland, 
Watson, & Grazier, 2012).  In the era of managed care, insurance companies, in having to make 
decisions on length of stay and rate of progress, demand markers of progress asking providers 
to communicate information such as estimate of treatment duration, rate of response, and 
sustainability of gains achieved.  Having the ability to better estimate response rate in patients, 
clinicians can more accurately, and with quantitative evidence, advise insurers of the anticipated 
trajectory of treatment in an effort to contribute to the efficient use of resources.  
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Purpose of Study 
Most published studies reporting the effectiveness of treatment of OCD in adolescents 
combine inpatient, partial hospitalization, and outpatient treatment modalities.  It was only 
recently that research has demonstrated the effectiveness of treatment for adolescent OCD in a 
residential setting (Bjorgvinsson et al., 2008; Leonard et al., 2014). Current research efforts are 
needed to enable clinicians to (1) better predict gains in real-world clinical settings and (2) 
identify risk factors for difficult-to-treat patients who have previously failed effective treatment 
strategies.  The purpose of this study is to investigate predictors of residential treatment 
outcome in adolescent patients receiving intensive combined treatment for a primary diagnosis 
of OCD.  This study seeks to empirically examine clinical factors within five relevant domains to 
determine whether predictors above and beyond baseline symptom severity are able to predict 
OCD treatment response in this population.  The literature has yet to address the relationship 
between potential predictors and treatment outcomes for pediatric patients receiving 
residential treatment.  The following research questions have been derived based on the 
literature identifying predictors of treatment outcome of pediatric patients with OCD receiving 
various types of non-residential treatment and adult patients receiving residential treatment for 
OCD.  The following research questions will be addressed and are labeled to correspond with 
later outlined methods: 
1. What is the relationship of potential predictors by domain (demographics, treatment 
history, comorbid symptoms, OCD symptom severity, and OCD symptom subtype) to 
treatment outcome? 
a. How well do demographic characteristics (age, gender, length-of-stay) at 
admission predict treatment outcome at discharge?   
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b. How well does treatment type prior to admission predict treatment outcome at 
discharge? 
c. How well do measures of symptom comorbidity (depression as measured by 
BDI-II; anxiety as measured by SCARED; anxiety sensitivity as measured by ASI; 
suicidality as measured by BDI-II Q#9) at admission predict treatment outcome 
at discharge?  
d. How well does OCD symptom severity (CY-BOCS-SR, including subtest scores) at 
admission predict treatment outcome at discharge? 
e. How well does OCD symptom subtype predict treatment outcome at discharge?   
2. How much improvement in prediction of treatment outcome is associated with the 
addition of identified predictors to OCD symptom severity at admission? 
a. If demographic variables (age, gender, length-of-stay) are found to significantly 
predict treatment outcome, what is the ability of these variables to predict 
treatment outcome at discharge, controlling for OCD symptom severity at 
admission?  
b. If treatment history is found to significantly predict treatment outcome, what is 
the ability of treatment history to predict treatment outcome at discharge, 
controlling for OCD symptom severity at admission? 
c. If measures of symptom comorbidity (depression, BDI-II; anxiety, SCARED; 
anxiety sensitivity, ASI; suicidality, BDI-II Q#9) are found to significantly predict 
treatment outcome, what is the ability of these measures to predict treatment 
outcome at discharge, controlling for OCD symptom severity at admission?  
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d. If OCD symptom subtype is found to significantly predict treatment outcome, 
what is the ability of OCD symptom subtype to predict treatment outcome at 
discharge, controlling for OCD symptom severity at admission? 
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CHAPTER 2: Literature Review 
Theoretical Models of OCD 
OCD is a disorder often characterized by cognitive and behavioral components (i.e., 
obsessions and compulsions), thus it makes intuitive sense that treatment follows the same 
trend.  CBT utilizes both behavioral-based therapeutic interventions that follow what is known 
about the human learning process as well as cognitively-based interventions that take into 
account the human experience and cognitive component of learning and behavior.  The 
theoretical basis for CBT in combination with ERP, as well as research to support the 
efficaciousness of this treatment, will be discussed.   Further discussion will review what is 
known about the biological basis of OCD and the history of and current uses of 
psychopharmacological interventions.   The format of discussion will be bottom-up in 
presentation thus building upon very early theories of learning to discussion of present 
treatment.  Current best practices and evidenced-based research supporting the use of these 
treatments will also be discussed.  Finally, patient response to treatment and predictability of 
outcome will be presented which will then lead into the purposes of this study. 
Learning Theory/Fear Acquisition 
The most widely accepted and empirically validated treatments for OCD are based on 
learning theory.   The learning process has been explained by two types of theories: stimulus-
response theory and cognitive theory.  Both will be briefly discussed. Grounded in the work of 
Hull, a stimulus-response theorist, Mowrer (1939), presented a two-factor theory of acquisition 
and maintenance of fear and avoidance learning.  He postulated that patients are motivated to 
escape or avoid anxiety.  This avoidance behavior is a learned response to signals or 
environmental cues that precede anxiety (conditioned stimuli or CS) that have been followed by 
an aversive event (unconditioned stimuli UCS) in the past.  The conditioned fear motivates the 
13 
 
 
 
occurrence of an escape response by the patient to eliminate the CS.  Additionally, Mowrer 
recognized that the avoidance behavior is repeatedly negatively reinforced as the patient 
escapes from the CS that elicits the UCR or fear or anxiety.   Based on observation in clinical 
trials, Mowrer concluded that fears are acquired in accordance with conditioning theory.  The 
strength of the fear is determined based on the intensity of the fear at pairing and the number 
of repetitions of the association between the fear and the stimuli.   It was also noted that this 
anxious response by an individual can generalize to stimuli similar to the original CS.  D’Amato 
(1966) extends Mowrer’s work explaining that individuals can also learn to avoid aversive stimuli 
(anxiety) through anticipation of the fear response.   D’Amato demonstrated that when rats 
were presented with discontinuous shock at various levels of intensity they displayed increased 
avoidance behaviors compared to rats receiving similar levels of continuous shock.   Cognitive 
theorists such as Tolman and Rotter believed that organism’s behaviors are purposive and goal-
directed not solely based on automatic associations.    Rotter (1954) proposed that individuals 
are able to distinguish reward value, estimate probability of obtaining reward, and have 
expectations of obtaining rewards.  He also presented a theory of locus of control that states 
that individuals have expectations of how much control they have in their environment.     
Rachman (1977) proposed revisions to the conditioning theory of fear acquisition in 
order to account for clinical examples that did not fit earlier theories.  Rachman proposed three 
“pathways” to the acquisition of fear: conditioning, vicarious exposures, and the transmission of 
information and instruction.  Rachman provided support for the conditioning theory but also 
addressed six scenarios in which individuals’ responses did not align with the conditioning 
theory of fear acquisition.  The first is that individuals did not demonstrate fear responses under 
otherwise fearful situations.  Through a systematic inquiry of 8000 individuals who experienced 
air raids during WWII, Lewis (1942) discovered that not all developed anxiety disorders.  In fact, 
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only 4% were reported as having acute reactions while 96% of individuals experienced anxiety 
that dissipated spontaneously.  Additionally, Rachman noted difficulty in creating conditioned 
fear in human subjects in laboratory conditions.  In an attempt to replicate Watson’s landmark 
study, Bregman (1934) failed in conditioning a group of 15 infants to neutral stimuli in the 
presence of a loud noise.  Similarly, Hallam and Rachman (1976) failed to elicit conditioned fear 
reactions in individuals who experienced electric shock over those who did not.  They found that 
conditioned fear did not resemble the cardiac responses that phobic patients experience when 
presented with their phobic stimulus, nor did subjects report the same anxiety or discomfort 
reported by phobic patients in the presence of the stimulus.   Third, equipotentiality, the 
concept that any two stimuli can become associated, or in this case that any stimulus can elicit a 
fear response if conditioned and that all stimuli have an equal chance of being transformed into 
CSs, is unsustainable.  For example, a conditioned fear has been obtained for snakes but not 
human faces (Ohman, Erixon, & Lofberg, 1975), caterpillars but not opera glasses (Valentine, 
1946), and rats but not wooden geometric shapes (Watson, & Rayner, 1920; Bregman, 1934).  
Seligman (1971) instead suggests that equipotentiality be replaced with preparedness and 
argued that phobias are of biological significance, are acquired readily, generalize broadly, and 
are more resistant to extinction.  The fourth addresses the epidemiological differences in 
conditioning across populations of individuals.  Agras, Sylvester, and Oliveau (1969) found that 
390/1000 people fear snakes while only 198/1000 fear a trip to the dentist, an interesting 
finding considering the exposure to snakes is not as common as dental visits.  Some fears are 
found to be more common than others regardless of exposure (e.g. children tend to have fear of 
darkness while not of pajamas (Rachman, 1977).  Interestingly, the most common obsessions 
reported for patients with OCD support this theory: fears of contamination, sickness, 
death/dying, and scrupulosity (i.e. feelings of extreme guilt about religious or moral issues) 
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(Steketee, 2005).  Fifth, conditioning theory fails to account for onset of fears.  Clinical 
observation of children and adolescents support this as they often have no account of the 
moment in which they developed a fear of germs but can, in hindsight, point out potential 
precipitating factors.  Finally, conditioning theory does not take into account Bandura’s 
observational learning.  Lewis (1942) observed correlations between mothers who experienced 
air raids and the development of anxiety disorders in their children.  Correlations of fears 
between mother and child have been reported between 0.59 and 0.67 (Hagman, 1932; John, 
1941).  In summary, Rachman provided evidence to suggest that information and instructional 
processes of fear acquisition explain failures to acquire fear in situations where conditioning 
theory would have been anticipated.  It was also suggested that fear acquisition can not only 
generalize but also discriminate between stimuli that are not dangerous and therefore not to be 
feared.   
Rachman (1977) provided evidence to lead to acknowledgement of biological 
differences in acquisition of fears which he calls “ease of connection” (p. 384).  He suggested 
that there is vulnerability and invulnerability between certain people and certain fear stimuli.  
This biological predisposition will be discussed further in review of biological theory and 
pharmacological treatment of OCD.  It addition to this biological predisposition, Rachman (1977) 
also hypothesized that “critical moments” may account for fear that is not provoked by 
recurrence of exposure but by intensity of stimulation in one exposure (p. 385).  In other words, 
one may acquire a fear to a stimulus otherwise categorized as neutral if that person is 
experiencing intense psychological or physiological states in the presence of that stimulus.   For 
example, individuals with panic disorder may develop agoraphobia after having a panic attack in 
the grocery store; thus an environment they had frequented hundreds of times in the past 
becomes a source of fear that thus is avoided.  For adolescents, this environment is often school 
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and other social environments.  The conditioning theory of fear acquisition is the basis for the 
development of behaviorally-based treatments designed to reduce this association between the 
aversive stimuli and the conditioned response.  Based within the Pavlovian fear conditioning 
framework (1927), researchers have well documented that once fear is acquired through 
association, the fear can be extinguished through consistent exposure of the neutral stimulus in 
absence of the unconditioned stimulus (Bouton, & Brooks, 1993; Vanelzakker, Dahlgren, Davis, 
& Shin, 2013).   
In addition to the conditioning theory of fear acquisition, additional theories suggest it is 
important to take into consideration vicarious acquisition of fear and information and 
instructional transmission of fear with respect to OCD.  This theory suggests that patients with 
OCD may have a biological predisposition to the development of fear in addition to an 
experience or critical event (e.g. start of high school, birth of a sibling, move) which increases 
vulnerability to acquisition of fear.  Modern understanding of fear acquisition also acknowledges 
the early work of cognitive theorists who contributed to our understanding that motivation, 
expectancy, and perception of control have significant impact on an individual’s approach to 
treatment (Hammond, 2005; Menzies et al., 2007).   The importance of the combined cognitive 
and behavioral approach in the treatment of OCD is that it directly addresses both the irrational 
belief systems as well as the ritualistic behaviors which plague individuals with OCD.   
Habituation Theory 
 The comprehension of habituation theory is essential when discussing behavioral 
treatment for anxiety.  The process of habituation epitomizes the mind-body connection in that 
it can be explained both physiologically and psychologically.  The physiologist may describe the 
process in terms of physical reactions to anxiety such as rapid heart rate, dilation of pupils, rapid 
respiration, and other symptoms occurring when the “fight or flight” response is stimulated by 
17 
 
 
 
the sympathetic nervous system which is then eventually countered by the parasympathetic 
response bringing the body back to a state of homeostasis.  Several constructs have been 
developed in the literature to attempt to explain the decrease in responsiveness to stimuli over 
time including fatigue (Sherrington, 1906), extinction (Pavlov, 1927), reactive inhibition (Hull, 
1943), and satiation (Glanzer, 1953).  Two landmark papers (Thompson, & Spencer, 1966; 
Groves, & Thompson, 1970) are the most commonly cited when describing behavioral 
characteristics of habituation in the literature.  The original work reviewed the existing 
habituation literature and organized nine characteristics that operationally defined habituation.  
It was stated that if an organism responded to repeated stimulation in conformance with these 
characteristics, it habituated (Thompson, & Spencer, 1966).  Groves and Thompson’s (1970) 
dual-process theory defined this progression in terms of an organism’s behavior such that with 
repeated stimulation behavioral response will decrease (habituate) in the same way, and with 
limited stimulation behavioral response will heighten (sensitization).      
The two-process theory has been applied minimally to the field of anxiety disorders.  
However, it has been suggested that the decline in both physiological and psychological anxiety 
during ERP for patients with phobias or OCD is a necessary condition for treatment benefits to 
occur (Bolton, & Perrin, 2008; Franklin, Freeman, & March, 2010; Marshall, & Segal, 1988).  
Lader and Wing (1964) described the decline in anxiety following exposure as habituation and 
succeeded in maintenance of the term in the literature in describing the phenomenon.   There is 
some discrepancy among theorists regarding degree of exposure and levels of arousal necessary 
for habituation to occur.  It has been theorized that low levels of arousal during exposure would 
aid in habituation for phobia (Lader, & Wing, 1964) and subsequent research has supported this, 
finding that high initial arousal during exposure impedes habituation (Foa et al., 1983).  These 
results conflict with the original observations of Lang, Melamed, and Hart (1970) who found that 
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individuals with high levels of anxious response to stimuli showed greater habituation and 
benefited from treatment more so than those with lower anxiety.   
It has been widely accepted that habituation plays a key role in the treatment of anxiety 
disorders in general and in OCD specifically.  It was not until recently that the principles of 
systematic desensitization and habituation were examined more closely within the context of 
the acquisition of fear.  In a recent review of literature, Craske, Lio, Brown, and Vervliet (2012) 
found support for an inhibitory model of fear reduction.  Evidence in the literature suggests that 
anxious individual’s fear minimization may occur not necessarily by the process of habituation 
but by a newly formed association, or re-learning process that occurs when feared stimuli are 
presented within a safe context.   
Treatment of OCD 
Rooted in the abovementioned theoretical frameworks, behavioral therapy has been 
well documented as the "gold standard" of treatment for obsessive-compulsive disorder in 
adults.  Cognitive-behavioral therapy (CBT) in combination with exposure response prevention 
(ERP), psychopharmacological or biological models, and combined models of treatment are 
recognized as both efficacious and clinically effective in treating adult OCD across settings 
(Abramowitz, Franklin, & Foa, 2002; Jenike, 2004; March et al., 1998).  Treatment for pediatric 
OCD has been a downward extension of practices and protocols found efficacious with adults.  
The progression of study started with single-case studies, case studies, and open clinical trials 
(Franklin, Freeman, & March, 2010).  Uncontrolled clinical trials with significant symptom 
reductions (e.g. Franklin et al., 1998; March, Mulle, & Herbel, 1994; Piacentini, Bergman, Jacobs, 
McCracken, & Kretchman, 2002) led to randomized studies evaluating the efficacy of ERP for 
pediatric OCD (e.g. Barrett, Healy-Farrell, & March, 2004; Bolton, & Perrin, 2008; POTS, 2004; 
Storch et al., 2007).  This will be highlighted below.  
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Biological Models 
Biological models will be briefly discussed providing background for the reader of the 
evolution of pharmacological intervention for pediatric OCD.  Rachman (1977) referred to an 
“ease of connection” eluding the potential for a genetic or heritability to OCD.  Genetic 
contributions are being investigated; however, researchers do not currently know who will or 
will not develop OCD based on these factors.  It has been established that there is increased risk 
of OCD in the relatives of individuals with the disorder.   Authors of the Obsessive-Compulsive 
Scale Child Behavior Checklist (OCS CBCL) found that scores are influenced more by genetic 
factors (approximately 55%) than unique environmental factors (approximately 45%; Hudziak et 
al., 2004).  In other words, these data provided evidence for a genetic influence of symptoms 
related to OCD in children ages 7-12 years old.  Several additional studies have also found 
support for a genetic component to the development of OCD (Cath, van Grootheest, Willemsen, 
van Oppen, Boomsma, 2007; Pauls, Alsobrook, Goodman, Rasmussen, & Lechman, 1995; 
Stewart, et al., 2013; Verkerk et al., 2003).   
Examination of brain functioning and pharmacological approaches in individuals with 
OCD was first completed in adults before examining this among children and adolescents.  
Through the use of imaging techniques, researchers found evidence for dysregulation in several 
areas of the brain including serotonin subsystems in the central cortex and orbiofrontal cortex 
(Breitera et al., 1996; Chamberlain et al., 2008).  In early uncontrolled trials, oral administration 
of seretoninergic medications paired with ERP was associated with a reduction in OCD 
symptoms (Riggs, & Foa, 1993).  The hypothesis that serotonergic  disregulation was 
contributing to OCD symptoms arose out of the observation that clomipramine, a serotonin 
reuptake inhibitor (SRI), relieved symptoms whereas noradrenergic reuptake inhibitors, those 
that target norepinephrine, did not.  Pharmacological interventions for pediatric OCD were 
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initiated following intensive studies on the use of Clomipromine Hcl with adult patients with 
OCD since the 1980s (Flament et al., 1985; Jenike et al., 1989).  In 1992, following a multi-center 
trial of Clomipromine Hcl, the Food and Drug Administration (FDA) approved its use in pediatric 
populations (Clomipramine Collaborative Study Group, 1991; DeVeaugh-Geiss et al., 1992).  It 
was found that 50-60% of patients taking clomipromine experienced at least a 35% reduction in 
OCD symptoms while symptom reduction for individuals in the placebo group was no more than 
5%.   
The effectiveness of SRIs in treating individuals with OCD supported the serotonin 
hypothesis (Barr, Goodman, & Price, 1993).  The serotonin hypothesis describes OCD pathology 
as an abnormal decrease of serotonergic (inhibitory) activity in the brain.  SRIs work to block the 
reuptake of serotonin in the synaptic gap thus ensuring an increased level of serotonin available 
in the synapse.  (Rosenzweig, Breedlove, & Leiman, 2002). Thus, while serotonin molecularly is 
not increased in number, the time spent in the synaptic gap is increased by the presence of the 
SSRI.   It is hypothesized that this increase in serotonin will decrease OCD symptoms.  The 
effectiveness of clomipromine on OCD symptoms led researchers to investigate the utility of 
other SSRI medications more selective for serotonin (i.e. SSRIs).  SRIs including fluoxetine, 
sertraline, paroxetine, and fluvoxamine have all demonstrated efficacy in symptom reduction 
and are approved by the FDA for treatment of OCD (Kozak, Liebowitz, & Foa, 2000).   
Additional studies measuring the efficacy of ERP alone, pharmacological intervention 
alone, and combined treatment efficacy and effectiveness in pediatric populations will be 
discussed.   While historically there had been fewer studies showing such efficaciousness and 
effectiveness for the pediatric population, recent research has well documented the 
abovementioned treatments as the gold standard for care for pediatric populations.   As a result, 
standard treatments for pediatric OCD include CBT and ERP for mild to moderate cases and CBT 
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with ERP combined with serotonin reuptake inhibitors (SRIs) for moderate to severe cases 
(American Academy of Child and Adolescent Psychiatry [AACAP], 2012; National Institute for 
Health and Clinical Excellence [NICE], 2005).   
Treatment Efficacy 
Numerous randomized controlled trials (RCTs) have demonstrated the efficacy of CBT 
alone (e.g., Barrett, Healy-Farrell, & March, 2004; Bolton, & Perrin, 2008; Bolton et al., 2011; de 
Haan, Hoogduin, Buitelaar, & Keijesers, 1998; Pediatric OCD Treatment Study [POTS] Group, 
2004; Piacentini et al., 2011; Storch et al., 2007; Williams et al., 2010) or in combination with 
SRIs (e.g., Franklin et al., 2011; POTS, 2004) for pediatric OCD.  The POTS (2004) study randomly 
assigned 112 pediatric patients (ages 7-17) to one of four treatment groups: SRI (sertraline), CBT, 
CBT and SRI, or pill placebo for a 12-week trial.  The sample was reportedly representative of 
youth with OCD seen in general clinical practice with moderate to severe OCD symptoms (as 
measured by the CY-BOCS-SR), with  80% of the sample having at least one comorbid psychiatric 
disorder.  Combined treatment was superior to CBT alone (p = .008), SRI alone (p = .006), and to 
placebo (p < .001).  The CBT alone and SRI alone conditions did not differ from one another (p 
= .80), and both were superior to placebo (CBT p = .003, SRI p = .007).   
Franklin et al., (2011) found that among 124 pediatric patients with OCD receiving 
pharmacotherapy with SRIs, the addition of intensive CBT provided by psychologists (MM+CBT) 
resulted in a significantly greater response rate, whereas augmentation of SRI with simple CBT 
instruction by psychiatrist (MM+I-CBT) did not.  Patients (age 7-17) with a primary diagnosis of 
OCD were randomly assigned to three conditions: medication management with SRI (MM), MM 
+ instruction on CBT procedures (MM+I-CBT), and MM + intensive CBT for a 12-week trial.  MM 
+ CBT was superior to both MM (p < .0001) and MM+I-CBT (p = .001), and MM+I-CBT and MM 
were not statistically significant from each other (p = .45).  In other words, for pediatric patients 
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already treated with an SRI, treatment that incorporates intensive CBT has been shown to be 
more efficacious than general CBT instruction alone.   
Evidence from the Child/Adolescent Anxiety Multimodal Study (CAMS) (Ginsberg et al., 
2011) also supports the efficacy of CBT and SRI as treatment of pediatric anxiety disorders.  A 
sample of 488 children and adolescents (ages 7-17) were randomly assigned to one of four 
treatment groups: SRT (sertraline), CBT, CBT and SRT (COMB), and placebo (PBO) for a 12-week 
trial measuring remission of symptoms of anxiety.  Results found that COMB treatment 
demonstrated significantly greater remission rates than CBT alone (p = .04), SRT (p = .03), and 
placebo (p = .01).  CBT alone and SRT alone did not significantly differ (p = .93) and both were 
superior to placebo (CBT p = .05, SRT p = .05).  Several meta-analyses provide additional support 
for the efficacy of CBT (Abramowitz, Whiteside, & Deacon, 2005; Olatunji, Davis, Powers, & 
Smits, 2013; Watson, & Rees, 2008).  
Storch et al. (2007) completed the only RCT to date examining intensive CBT for 
pediatric OCD.  In this study, forty children and adolescents (aged 7-17) with a primary diagnosis 
of OCD were randomly assigned to either: 1) 14 weekly traditional sessions or 2) 14 intensive 90-
minute sessions each weekday for three weeks.  The intensive delivery of CBT through 
concurrent weekday sessions over three weeks resulted in slightly better remission and 
improvement rates at post-treatment.  While there were no significant differences across 
conditions by three-month follow-up, at post-treatment 75% of youth in the intensive group 
compared to 50% in the weekly group met remission status criteria.  Overall, while no between 
group differences were obtained (p = .15), a significant within group main effect was identified 
for the CY-BOCS from pre-to post-treatment (p = .001) demonstrating that intensive CBT was 
equally as effective as weekly CBT sessions for this sample.   
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 Although CBT has been identified as an efficacious treatment for pediatric OCD, many 
adolescents are unable to access treatment because of barriers such as shortage of trained 
professionals and geography (Storch et al., 2007).  The solution sought by many parents of 
children and adolescents with OCD is intensive OCD treatment.  With need comes the 
emergence of programs offering intensive treatment for pediatric OCD and the need for 
effectiveness studies targeting this population.   While RCTs have provided the field with 
evidence supporting the efficacy of CBT in treating pediatric OCD, such studies are often lacking 
in external validity.  For example, unlike patients treated in clinical settings, RCT subjects are 
typically required to consent to one of several conditions of treatment, limiting them to either 
SRI or CBT treatment (e.g., Barrett, Healy-Farrell, & March, 2004; Storch et al., 2007).  
Furthermore, RCTs often prescribe exclusionary criteria to subjects which excludes most 
patients who have failed an SRI trial or CBT historically (e.g. Franklin et al., 2011; POTS, 2004), 
patients without a “stable” dose of SRI (Bolton et al., 2011), or patients with comorbid 
psychiatric disorders (e.g. Storch et al., 2007) or learning disabilities (Bolton et al., 2011).  
Therefore, examination of pediatric OCD treatment outcomes in naturalistic settings is 
warranted to test the limits of these treatments beyond the academic medical context to 
examine its effects with more complex patients who would not meet criteria for RCTs.   
Treatment Effectiveness  
 There is very little research to date investigating the effectiveness of intensive CBT 
treatment in pediatric populations with OCD.  Franklin et al. (1998) and Storch et al. (2006) have 
demonstrated significant symptom reduction in open trials investigating the effectiveness of 
intensive CBT while others have reported significant improvement with shorter-term intensive 
treatment (Whiteside, Brown, & Abramowitz, 2008; Whiteside, & Jacobsen, 2010) which was 
sustained at five-month follow-up (Whiteside, & Jacobsen, 2010).  Evidence also exists to 
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support the effectiveness of intensive outpatient group settings for treatment of pediatric OCD 
(Olino et al., 2011).  
More intensive CBT allows clinicians to increase the treatment “dose,” which may be 
helpful for patients with more severe or complex presentations.   These patients may require 
more focused interventions consisting of multimodal treatments, intensive monitoring due to 
severe symptoms, and delivery of ERP at a more intensive level than outpatient providers, and 
parents, are able to provide.   Typically acute inpatient settings focus on short-term mood 
stabilization and do not provide the type of specialized treatment these patients require.   
Residential treatment meets the needs of these patients with increased duration and intensity 
of CBT, removal from dynamics within the family setting that has accommodated anxiety, and 
constant staff monitoring and therapeutic support to assist with ritual prevention, assigned 
exposure completion, and other treatment goals.   
While research has shown the effectiveness of combined treatment with adult patients 
with OCD in intensive residential settings (e.g. Stewart et al., 2004), there is little evidence 
examining the effectiveness of CBT provided to adolescents with OCD in residential settings.  
One open clinical trial measured the effectiveness of CBT with adolescents receiving treatment 
within a residential setting during 2005 and 2006 (Bjorgvinsson et al., 2008).  A total of 49 
patients were admitted during this time period, 23 of which were included in the study due to 
having a primary diagnosis of OCD.  Participants (aged 13-17) included 11 girls and 12 boys who 
were primarily Caucasian (95.9%).  Sixty-five percent had comorbid diagnoses (mood disorder 
35%, ADHD 17%, developmental disorder 17%, other anxiety disorder 13%, and other 
psychiatric disorders 18%) and the average length of stay was 9.5 weeks (SD = 3.96).  Almost all 
of the adolescents admitted to the program had previously failed to respond to outpatient 
treatment.  The CY-BOCS (Scahill et al., 1997) was used to measure OCD symptom severity and 
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identify OCD-related thoughts and beliefs.   Results indicated significant decreases in OCD 
symptom severity from pre- to post-treatment, with a large effect size (Cohen’s d = 1.15).  
Consistent with tests of statistical significance, the Reliable Change Index (RCI) (Jacobson, & 
Truax, 1991) showed that 70% of the patients demonstrated clinically significant decrease in 
their CY-BOCS scores.  In other words, this study provided initial support for the effectiveness of 
residential treatment for a small sample of adolescents with OCD.   
 Leonard et al. (2014) examined outcomes from a larger sample of adolescents who 
received residential treatment for OCD.   Participants included 172 adolescents with primary 
OCD who received CBT in combination with ERP in a residential treatment program between 
2005 and 2013. Participants included 89 (51.7%) males and 83 (48.3%) females whose primary 
ethnicity was Caucasian (89%), who were on average 15.45 years old, and had an average length 
of stay of 78 days (SD = 36).   Eighty-two percent of participants had comorbid diagnoses with 
45% of patients with three or more diagnoses.  The most common co-occurring diagnoses were: 
mood disorder not otherwise specified 82%, attention deficit/hyperactivity disorder 36%, major 
mood disorder 36%, autism spectrum disorder 20%, generalized anxiety disorder 19%, and social 
anxiety disorder 17%.  Most of the patients had failed outpatient treatment (90.1%), received 
inpatient treatment (39.5%), or been enrolled in another type of intensive outpatient or 
residential program (40%).  Treatment consisted of CBT in combination with ERP with patients 
receiving approximately 26.5 hours of ERP work weekly.  Results demonstrated significant 
decreases in OCD symptom severity, as measured by the CY-BOCS-SR, from admission to 
discharge (p < .001).  Reliable Change Index (RCI) analysis is consistent with the tests of 
statistical significance in that 64% of patients met criteria for clinically significant change.   
Follow-up data t(43) = 0.602, p = .55 demonstrated that gains in OCD symptom severity were 
maintained from post-treatment (M = 11.00, SD = 5.96) to follow-up (M = 10.30, SD = 7.88).   
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Predictors of Treatment Response 
Although evidence exists for the effectiveness of a combination treatment for pediatric 
OCD, many patients do not respond to various levels of treatment.  Rates of response have been 
reported ranging from 67-86% at post treatment (Franklin et al., 1998; Whiteside, & Jacobsen, 
2010; Storch et al, 2006) and 50-62% at follow-up (Franklin et al., 1998; Storch et al, 2006).  
Despite favorable responses in these trials, an alarming 33-50% of patients do not respond to 
various levels of treatment.  More specific to residential treatment for pediatric OCD, 
Bjorgvinsson et al. (2008) reported that 70% of their patient sample demonstrated clinical 
significant decreases in symptoms leaving 30% of patients with seemingly unchanged symptom 
severity at after intensive treatment.    Similarly, Leonard et al. (2014) reported 64% of patients 
met criteria for clinically significant change while 36% did not.  Residential treatment has been 
identified as the most restrictive placement for individuals with OCD when all other therapeutic 
interventions have been exhausted without improvement of symptoms.   It is unknown what 
factors contribute to poor response rate in 30-36% of adolescent patients in residential 
treatment most of whom have failed numerous SRI trials and treatment modalities prior to 
seeking this intensive treatment.    Identification of factors that predict response to treatment in 
this population is valuable information for clinicians.  If patients with certain “risk factors” 
known can be identified at admission, treatment providers can preemptively offer modifications 
or augmentations of treatment prior to poor treatment response.   This strategy will also aid in 
the careful allocation of resources at this level of care.  Given the costliness of residential 
psychiatric programs it is imperative to consider effective but efficient delivery of treatment in 
these programs.   
The literature examining predictors of combined treatment outcomes for pediatric 
patients with OCD is limited.  Many studies attempting to identify predictors of response in 
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pediatric patients have started by investigating predictors from adult literature (Keeley, Storch, 
Merlo, & Geffken, 2008).   In a systematic review of the adult literature, Knopp, Knowles, Bee, 
Lovell, and Bower (2013) found that the most commonly assessed predictors of treatment 
outcome for primary OCD are symptom severity, illness duration, symptom subtypes and 
symptom-specific variables, obsessive-compulsive beliefs, age of onset, depression severity, 
medication use, past treatment, and anxiety severity.  Additionally, of the demographic 
variables investigated, age, gender, employment, education, relationship status, and treatment 
expectancy were most commonly assessed.  None of the studies reviewed evaluated patients 
within a residential treatment setting and, despite the commonality among factors identified as 
potential predictors, conflicting results are reported.  Ginsburg, Kingery, Drake, and Grados 
(2008) present the only review to date investigating potential predictors of treatment response 
in pediatric patients with OCD.  Included in the review were a total of 21 studies.  Studies 
included RCTs and uncontrolled studies measuring the effectiveness of CBT alone, medication 
alone, and CBT in combination with medication.  Nine predictors were identified and included: 
gender, age, duration of illness/age of onset, baseline severity of OCD symptoms, type of OCD 
symptoms, comorbid disorders, psychophysiological factors, neuropsychological factors, and 
family factors.    
Demographic.  A total of 11 of the 21 studies reviewed by Ginsburg et al. (2008) 
investigated gender as a predictor of treatment outcome.  Only one study (RCT – medication 
only) found that gender was a significant predictor of treatment response (Flament et al., 1985).   
Males showed a greater response to treatment than females (p=.05) but results need to be 
interpreted with caution due to the unequal distribution of patients and patient attrition.  
Twelve of the 21 studies reviewed investigated age as a predictor of treatment response.  In the 
CBT-only and combination studies, age was not found to be a significant predictor.  Only one 
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study (medication-only RCT) found a significant relationship between age and treatment 
response (Riddle et al., 2001).  It was found that younger patients responded more favorably to 
SRI than did older patients.   
 Age and gender have found to be significant predictors of compulsive symptoms in a 
population of 350 German patients in a child and adolescent clinic (Kirkcaldy, Furnham, & Siefen, 
2010).  In this population, females were found to be more likely than males to exhibit high levels 
of compulsive behavior which may explain why Flament et al. (1985) found males to respond 
better when compared to females.  In a more recent outpatient sample (N = 112) of pediatric 
patients with primary OCD, neither age nor gender were found to significantly predict or 
moderate treatment outcome (age, F = .51; gender, F = .03; p > .05) (Garcia et al., 2010).   
Treatment history.  No study to date has investigated previous treatment attempts in 
relationship to future treatment outcome with adolescents with OCD.  This is likely because 
most outcome studies are measuring the effectiveness of their program most of which are 
treating patients either for the first time or patients that have sought a higher level of care after 
outpatient treatment was ineffective.  Patients in residential treatment have often tried various 
intensities of treatment without success.  Due to the specificity of this population and the lack of 
empirical data in the literature, it is of interest whether previous treatment attempts (by 
program type) are able to predict residential treatment outcome in adolescent patients with 
OCD.  Program types vary in their intensity; this is especially the case for outpatient treatment 
(e.g. Franklin et al., 1998; Storch et al., 2006). For the purposes of this study, categorization of 
treatment type will be discussed in the next chapter. 
Comorbid symptoms.  Psychiatric comorbidity was examined in 10 of the 21 studies 
reviewed by Ginsburg et al (2008).  Barrett et al. (2005) found that baseline self-reported levels 
of anxiety and depression (Multidimensional Anxiety Scale for Children, Children’s Depression 
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Inventory) did not predict treatment outcome at 18-months.  Flament et al. (1985) reported 
change in OCD symptoms at 11-weeks was independent of baseline depression scores.  
However, Piacentini et al. (2002) found that higher levels of child anxiety as reported by parents 
were associated with poorer outcomes at posttreatment.    Storch et al. (2010) found that 
depressive symptoms predicted impairment after accounting for OCD symptom severity.  
Theories indicate that depressive symptoms may create information processing biases or 
contribute to negative cognitive styles which impact self-reported symptoms or impact 
children’s ability to clearly identify irrational thinking (Timbremont, & Braet, 2004; Storch et al., 
2010).  Despite evidence in the literature demonstrating association between other anxiety 
symptoms and impairment of functioning in pediatrics (Angst et al., 2005; Grabe, Thiel, & 
Freyberger, 2000; Storch et al., 2009), Storch et al. (2010b) did not find predictive validity in 
non-OCD anxiety symptoms to predict OCD functional impairment over and above OCD 
symptom severity.  In another sample, Garcia et al. (2010) did not find predictive value of 
anxiety symptoms as measured by the Multidimensional Anxiety Scale but did find that 
externalizing symptoms (ADHD), when rated by parents, were predictive of poorer treatment 
outcome(CPRSL – Global Index Score).    
When symptoms of anxiety and depression were used as a predictor for compulsive 
behaviors alone, both were found to be significant predictors (Kirkcaldy et al., 2010).  The 
authors provide an interesting hypothesis in that the adolescent population in the study may be 
exhibiting heightened social anxieties due to elevated levels of insecurity resulting from their 
disorders.  Typically developing adolescents are experiencing a heightened level of social 
insecurity but when compounded by psychiatric illness this developmental trajectory may 
increase the likelihood of comorbid anxiety and depressive symptomology that may impact 
treatment outcome differently for adolescents than other populations with psychiatric illness.  
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While suicidality was not used as a predictive factor in analysis Kirkcaldy et al. (2010) found that 
almost 40% of their sample of pediatric patients with OCD had reported previous suicidal 
behavior.  No other study to date has investigated suicidal ideation as a related factor to 
treatment outcome in adolescents with OCD.  Similarly, anxiety sensitivity, as measured by the 
ASI, has been found to be significantly associated with OCD symptoms severity across OCD 
symptom subgroups (Calamari, Rector, Woodard, Cohen, & Chik, 2008). 
OCD severity.   OCD symptom severity has consistently been found to significantly 
predict overall impairment in pediatric populations (Piacentini, Bergman, Keller, & McCracken, 
2003; Piacentini, Peris, Bergman, Chang, & Jaffer, 2007; Storch et al., 2010; Valderhaug & 
Ivarsson, 2005) and is associated with longer time to remission (Bloch et al., 2009).  Twelve of 
the 21 studies examined by Ginsburg et al. (2008) investigated baseline severity of OCD 
symptoms as a predictor of treatment response.  Two CBT-only studies found severity of OCD 
symptoms at baseline was associated with a poorer treatment response (Piacentini et al., 2002; 
Barrett, Farrell, Dadds, & Boulter, 2005).  Piacentini et al. found that more severe obsessions on 
the CY-BOCS and poor OCD-related academic impairments (Child OCD Impact Scale School score) 
significantly predicted poorer treatment outcomes at post-treatment (NIMH Global OCD Scale 
score).  Following an RTC, Barrett et al. (2005) investigated how well pretreatment OCD severity, 
self-reported depression and anxiety, and parent-reported family functioning predicted 
outcome in a population of 48 children and adolescents (8-19 years of age).  Significant 
predictors of long-term treatment outcome (18-month) included more severe obsessions, more 
severe compulsions, and a higher level of family dysfunction when compared to baseline 
depression and comorbid anxiety (Barrett, Farrell, Dadds, & Boulter, 2005).   In an open SRI trial, 
Wagner et al. (2003) investigated the predictability of age, duration of illness, and baseline CY-
BOCS scores as potential predictors of remission (CY-BOCS score of ≤8).  Only baseline CY-BOCS 
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scores were found to be a significant predictor (p < .001).  More recently, baseline OCD 
symptoms was found to significantly predict treatment outcome (F = 41.12, p < .001) above and 
beyond demographic and all other cormorbid symptoms except externalizing disorders (F = 8.52, 
p < .01) (Garcia et al., 2010).  Additionally, parental report of functionality (as measured by the 
Child OCD Impact Scale – Parent report), externalizing symptoms (as measured by the Conners 
Parent Report Scale – Long Version), and child insight (as measured by the Fixity of Beliefs Scale) 
were found to be significant predictors of treatment outcome for this sample.   
OCD symptom subtype.  Type of OCD symptom presentation refers to the subtypes of 
obsessions and compulsions that may be related to treatment response.  Examples are 
contamination obsessions that are related to cleaning obsessions or compulsive behaviors such 
as hoarding.   Symptoms have been found to cluster around five subtypes including: 
symmetry/ordering, contamination/cleaning, sexual/religious obsessions, aggressive/checking, 
and hoarding dimensions (Mataiz-Cols, Rosario-Campos, & Leckman, 2005).  The literature has 
consistently found poorer treatment outcome for patients with hoarding symptoms 
(Abramowitz, Franklin, Schwartz, & Furr, 2003; Bloch et al., 2009; Masi et al., 2005) and primary 
obsessional symptoms with associated “mental” rituals (Alonso et al., 2001; Rufer, Fricke, Moritz, 
Kloss, & Hand, 2006).  Overall remission rates of childhood-onset of OCD by adulthood has 
found to range from  40-59% (Stewart et al., 2004) but that rate decreases to 10% of children 
with primary hoarding symptoms (Bloch et al., 2009).  Contamination and checking symptoms 
have generally been found to respond the best to treatment (CBT; Abramowitz et al., 2003; Masi 
et al., 2005) with one exception of pediatric patients with aggressive/checking symptoms who 
responded better to CBT when compared to patients without this feature (Storch et al., 2008).  
Despite evidence of better response to treatment contamination/cleaning and 
aggressive/checking symptoms have been found to be significantly associated with greater 
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functional impairment (Storch et al., 2010b).  Similarily, Masi et al. (2005) found that children 
with predominately contamination/cleaning symptoms were more impaired at baseline (p 
= .008) but had the highest response rate (78%) to pharmacotherapy when compared to other 
groups.  This rate was significantly better than the response rate of patients with hoarding 
symptoms (14%, p = .008).   
 To date, no clear statistical evidence exists in the literature that provides strong support 
for the predictability of treatment outcome for OCD.  The literature on the predictive factors of 
OCD treatment outcomes is inconclusive and lacking in the pediatric literature.  The strongest 
factor across all studies reviewed was pre-treatment symptom severity.  No studies investigated 
predictors of treatment in residential settings and very few predictive factors in adolescent 
patients.  One benefit from the investigation of predictors within a residential setting is the 
controlled nature of treatment delivery and environmental influences (i.e. parental 
accommodation) when compared to outpatient studies.   This information, while lacking in 
external validity due to the scarcity of such programs, has strong internal validity and clinical use 
for this specific population.    
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CHAPTER 3: Method and Procedure 
 This study is retroactive in nature, in that a sample was drawn from data collected by 
Rogers Memorial Hospital Outcomes Department between January 2009 and May 2014. The 
data used in this study is part of a larger existing set of data collected by the Hospital for the 
purposes of measuring program outcomes as well as other research projects.  Approval was 
obtained by Rogers Memorial Hospital Research Review Committee to access data and complete 
analysis.  This chapter will describe the participants, setting, treatment, measures, and 
procedures.  
Participants 
Table 1 presents demographic data for the participants in the study.  Participants from 
this study were recruited from 230 adolescent patients with a primary diagnosis of OCD, as 
outlined in the DSM-IV-TR (APA, 2000), who were admitted to the Child and Adolescent Center 
at Rogers Memorial Hospital between January 2009 and May 2014. Diagnoses made during this 
time period were based on the DSM-IV-TR but as minimal change has occurred for diagnostic 
criteria for OCD with the updated version of the DSM (that is, DSM V), cross version diagnoses 
should not differ. OCD is established as the primary diagnosis at admission and is based upon 
the Center Medical Director’s review of pre-admission screenings as well as a clinical intake 
interview from the attending physician, both of whom are licensed child and adolescent 
psychiatrists with expertise in OCD.  Only patients who completed the Children’s Yale-Brown 
Obsessive-Compulsive Scale – Self Report (CY-BOCS-SR; Piacentini, Langley, & Roblek, 2007) at 
admission and discharge and have a score of 16 or greater on the CY-BOCS-SR at admission 
(indicating clinically significant symptoms) were included in the sample.  In the rare case that a 
participant had multiple admissions to the program, their first admission meeting the inclusion 
criteria were included in the sample.   
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Based on the inclusion criteria, 196 participants were included in the sample. 
Participates range from 13 to 17 years of age with a mean of 15.41(1.20).  There are 99 males 
and 97 females in the sample with average ages 15.52(1.15) and 15.31(1.24) respectively.  All 
participates were taking medications for OCD or another psychological disorder during their 
hospital treatment.  Length of stay for patients in the current intent-to-treat sample ranged 
from 5 to 208 days with an average length of stay of 76.67 days (SD = 35.10). 
Table 1 
Demographic Characteristics of Participants (N=196) 
  N %age of total sample 
        
Gender 
 Male 99 50.5  
 Female 97 49.5  
Treatment History  
 Outpatient 132 67.3 
 Inpatient 88 44.9 
 IOP 61 31.1 
 PHP 68 34.7 
 Res 61 31.1 
Symptom Subtype 
 SORC 82 41.8 
 CCAS 36 18.4 
 H 20 10.2 
 SR 20 10.2 
Note.  IOP=intensive outpatient program; PHP=partial hospitalization or day treatment program; 
Res=residential treatment; SORC=symmetry, ordering, repeating, and checking; CCAS=contamination, 
cleaning, and aggressive and somatic symptoms; H=hoarding obsessions and compulsions; SR=sexual and 
religious symptoms; N for treatment history and symptom subtype do not equal total sample due to 
patients having received multiple treatments or endorsing simultaneous symptom subtypes. 
Setting  
The Child and Adolescent Center is a 24-bed residential treatment facility designed to 
treat adolescents (age 14 to 18) with OCD and other coexisting disorders who have not 
responded to outpatient treatment.  The Center is divided into two co-ed wings with 12 beds 
each.  Each wing has at least two staff present from 0700 to 2300 and one night staff present 
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overnight.  On the first full day of participation in the intensive program, patient receives 
education regarding the theory and rationale of ERP, a detailed explanation of how to conduct 
exposures and ritual prevention, and orientation to the unit including rules and responsibilities.  
Treatment 
Treatment is represented and will be categorized into three distinct and on-going 
phases of the residential program: assessment, treatment, and follow-up.   Procedure for each 
stage is described in detail below. 
Assessment.  Table 2 presents a list of assessments by treatment provider during phases 
of the program.   Most patients are referred to the program by therapists, psychologists, 
psychiatrists, educational consultants, or former patients while some parents or patients 
themselves find the program independently.  Regardless, each potential patient or patient’s 
family contacts the program admissions specialist and completes a comprehensive screening 
process via phone prior to consideration for the program.  This screening is then reviewed with 
the Medical Director, the program’s manager, and the program’s admissions specialist.  Patients 
with active psychosis, mania, suicidality or homicidality; electroconvulsive therapy within the 
past 30 days; mental retardation; or history of physical violence are not recommended for 
admission into the program.   
Once admission is scheduled, the attending psychiatrist, RN, and therapist will meet 
with the patient and family for 1-2 hours each to complete a comprehensive clinical interview 
(including pertinent medical, family, psychiatric, treatment, and medication history) reviewing 
presenting problems and confirming the OCD diagnosis.  Also at this time, parents are provided 
with admissions assessments and both patients and parents are offered informed consent (see 
Appendix A) for assessment data to be used for outcome research.  New admissions are 
assigned a primary therapist, an educational specialist, and a behavioral specialist.  Primary 
36 
 
 
 
therapists are masters-level licensed clinicians who specialize in CBT and other 
psychotherapeutic modalities.  Therapists assess presenting problems including social, 
educational, and familial impacts of diagnosis and formulate a treatment plan to present to the 
multidisciplinary team.  Educational therapists complete the Wide Range Test of Achievement 
(WRAT), contact the patient’s school, and collect pertinent educational materials upon 
admission.   
The behavioral specialist administers a battery of admission assessments including the 
CY-BOCS-SR Symptom Checklist and Severity Rating Scale.  The Symptom Checklist includes 
more than 50 examples of obsessions and compulsions.   The Symptom Checklist is administered 
through a semi-structured interview process and is intended to facilitate symptom identification 
which aids hierarchy construction.  This measure is not designed to be scored nor is it usually 
necessary to re-administer during the course of treatment.   Using the information from the 
admissions assessments and from an admissions interview, the behavioral specialist begins to 
develop an exposure hierarchy with the patient.  The behavioral specialist asks patients to rate 
their perceived anxiety when given examples of in-vivo or imaginary exercises.  Patients are 
asked to rate their anxiety from zero to seven, with zero being “no anxiety” and seven being “in 
a state of panic”.  This scale is based on the Subjective Units of Distress Scale (SUDS) developed 
by Wolpe (1990).   
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Table 2  
 
Assessment by Treatment Provider per Patient through Program Phases 
 
Treatment Pre-    
Provider Treatment Admission Discharge  
Admissions  Phone  
Specialist Screening Screening 
 CY-BOCS-SR 
 
Program Review of  Introduction to  
Manager Screening Program 
 
Psychiatrist Review of  Clinical Interview Discharge Summary 
 Screening  
Primary  Admissions Assessment 
Therapist  Treatment Plan 
 
Registered  Admission Assessment 
Nurse  Suicide Risk Assessment  
 
Behavioral  Patient: Patient: 
Specialist  CY-BOCS-SR CY-BOCS-SR 
  BDI-II/QIDS-SR BDI-II/QIDS-SR 
  LSAS-SR LSAS-SR 
  ASI ASI 
  CSDS CSDS 
  MFQ-Child MFQ-Child 
  PQ-LES-Q PQ-LES-Q 
  BADS-SF BADS-SF 
  SCARED-Child SCARED-Child 
  Child Disgust Scale Child Disgust Scale 
  *Child Behavior Checklist *Child Behavior Checklist 
  *CSDS-P *CSDS-P 
  *SCARED-Parent *SCARED-Parent 
  *MFQ-Parent *MFQ-Parent 
 
Education  WRAT 
Therapist   
 
Dietician  Dietary Survey 
*denotes assessments completed by parents 
  Treatment. Residential treatment described below provides CBT based on components 
found in the CBT Treatment Manual (March, Mulle, & Herbel, 1998) and has been used in 
previous collaborative studies of treatment for pediatric OCD (POTS, 2004; Franklin et al., 2011).  
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Components include 1) psychoeducation, 2) cognitive training, 3) development of treatment 
hierarchies to arrange feared situations from least to most anxiety provoking to guide exposure 
treatment, and 4) ERP.  Table 3 provides a summary of treatment delivered by provider with 
estimated duration.  Similar to CBT procedures described by Freeman et al. (2009) sessions (5x 
per week) generally consist of a statement of treatment goals, review of previous exposure trials, 
provision of new information, therapist-assisted practice, homework, and monitoring of 
therapeutic work.   
Table 3 
Treatment Delivery by Treatment Provider  
Psychiatrist Medication management 
 Psychoeducation, Psychotherapy 2-3hrs/week 
 Family Therapy 1hr/week 
 
Primary  Individual CBT Therapy/Psychotherapy  1-2hrs/week 
Therapist Group Therapy 5hrs/week 
 Family Therapy 1hr/week 
 
Registered Medical Monitoring as needed 
Nurse 
 
Behavioral  Bi-monthly Assessment per diagnosis 
Specialist Family Therapy 15-30min/week 
 Supervision of Independent Exposure Work 15hrs/week 
 Individual ERP 75min/week 
 Group CBT 3hrs/week 
 
Educational  Schoolwork Support 7hrs/week 
Therapist 
 
Dietician Dietary Assessment/Meal Development as needed 
 
Experiential  Adventure-based Therapy 7.5-10hrs/week 
Therapist Art Therapy 2-3hrs/week 
 The ERP program is delivered each week-day in a three-hour block of time.  Table 4 
presents the sequential components of ERP.  During this block patients participate in (1) a check 
in group (15-20 minutes) where patients report their recorded exposure trials and “bans,” (2) 
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*individual sessions with their behavioral specialist (each lasting 30-45 minutes), (3) supervised 
exposure work with other staff, and (4) self-exposures. They are also assigned 90-minutes of 
exposure homework each day to practice assigned exposures without ritualizing.  All behavioral 
specialists underwent intensive 6-month training and receive weekly individual supervision from 
a licensed psychologist.    
Table 4 
 
Components of Exposure Response Prevention (ERP) in Treatment 
Exposure (E) 
1. Patents complete the CY-BOCS-SR Symptom Checklist. 
2. BS asks patient to rate examples of proposed exposures based on 0-7 SUDS scale. 
3. Less anxiety-producing exposures are placed lower in the hierarchy while panic-inducing 
exposures are placed at the top. 
4. BS assign patients level 3 exposures that are challenging yet manageable. 
5. Patients are asked to expose themselves to their feared stimuli, rate their peak anxiety, and 
continue until their peak anxiety has decreased by half to achieve within-trial habituation. 
6. Patients complete the same exposure in succession five times to achieve between trial 
habituation.   
7. Patients are then asked to record their peak anxiety, the lapsed time, and ending anxiety 
rating. 
8. Patients are to wait at least two minutes between trials before starting a subsequent trial. 
9. BS instruct patients to discontinue an exposure if the patient has achieved zero anxiety on at 
least three trials on two separate days.   
Response Prevention (RP) 
1. Simultaneously, patients are asked to disengage in compulsions. 
2. BS assigns the patient “bans” which is short banned behaviors or compulsions. 
3. Patients are asked to keep a daily tally of when they submit to an urge to perform a 
compulsion and resists when they have an urge to perform a compulsion and do not.   
Psychiatrists see patients at least weekly to monitor medications.  Nurses see patients 
as needed regarding general medical conditions.  Primary therapists meet with patients once or 
twice per week independently (to provide psychotherapy) and in a group format every weekday 
for 60-minutes (to obtain statement of goals, provide psychoeducation, and facilitate peer 
support).  In addition, therapists hold weekly family sessions to provide psychoeducation to 
families, to discuss how members of patient’s family can support treatment, to update the 
family on patient progress, and to discuss follow-up treatment.  Primary therapists receive bi-
weekly individual supervision and bi-weekly group supervision.  The educational therapist 
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attends to patient’s educational needs, facilitating school work between home-school and 
program, seeing each patient for approximately 1.5-2 hours each weekday.   In addition to the 
abovementioned, patients received art therapy two time per week for a total of 4 hours and 
experiential therapy either three or five times per week for a total of 15 hours per week. 
Each patient’s CBT treatment is individualized and constructed to maintain 
developmental appropriateness (Freeman et al., 2009).  Behavioral specialist and primary 
therapists maintain flexibility adjusting the level of discourse to specific interests, level of 
cognitive functioning, social maturity, and capacity for sustained attention for each patient.  For 
example, adolescents who are more sensitive to the impact their OCD symptoms have on social 
interactions, are less likely to utilize a persona for their OCD, and take a more active role in 
directing their treatment than children of a younger age.  Additional differentiation in treatment 
is necessary for patients whose OCD has become entangled with family members (e.g. excessive 
reassurance, parental accommodation, etc.) requiring greater attention to family involvement in 
exposure work.    
Typically, patients are discharged when they had achieved 70-75% completion of their 
hierarchy with ritual prevention.  Patients are discharged prior to this benchmark sometimes 
due to parental preference, termination of funding, or refusal of treatment by patient.  Within 
48 hours of discharge, patients are asked to complete the same battery of assessments that 
they completed upon admission, with the exception of the CY-BOCS-SR Symptom Checklist.  
Both patient and parent are again provided with informed consent (see Appendix B) to be 
contacted post-discharge for follow-up assessment. 
Measures and Procedures 
Dependent measure. The CY-BOCS (Scahill et al., 1997) is a well-established measure to 
assess OCD that was developed following the establishment of the Yale-Brown Obsessive-
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Compulsive Scale for adults (Goodman et al., 1989a; Goodman et al., 1989b). The self-report 
administration of the CY-BOCS, the CY-BOCS-SR, was used in the present study.  The CY-BOCS-SR 
has demonstrated strong psychometric properties and is significantly correlated with the 
interview-based CY-BOCS (r = .77; Conelea, Schmidt, Leonard, Riemann, & Cahill, 2012).   The CY-
BOCS-SR includes a Symptom Checklist and a Severity Rating Scale.  The CY-BOCS-SR Symptom 
Checklist is a self-report survey covering 54 obsessions and compulsions rated for their current 
and past presence.  The Severity Rating Scale is a 10-item self-report assessment that includes 5 
questions related to obsessions and 5 questions related to compulsions.  Severity of obsessions 
and compulsions are rated on a five-point Likert scale (0-4) that outlines time spent, 
interference with functioning, distress, resistance, and control over symptoms within the past 
two-weeks.  A total severity score is calculated ranging from 0 to 40 (0-7=subclinical, 8-15=mild, 
16-23=moderate, 24-31=severe, and 32-40=extreme; Goodman et al., 1989b) by adding 
subscales for obsessions (0-20) and compulsions (0-20).  Unless otherwise indicated, reference 
to the CY-BOCS-SR throughout this proposal will be referring to the Severity Rating Scale by 
patient self-report.   
Considered the 'gold standard' measurement of pediatric OCD, the CY-BOCS has 
demonstrated strong reliability, validity, and treatment sensitivity.  Internal consistency has 
been reported to be high for the total (r = 0.87), obsessions (r = 0.91), and compulsions (r = 0.68) 
scales (Scahill et al., 1997; Storch et al., 2004b).  The CY-BOCS has shown excellent interrater 
agreement (interclass correlations ICCS 0.66-0.91) (Scahill et al., 1997) and good 6-week stability 
(ICC 0.79; Storch et al., 2004b).  The measure has demonstrated treatment sensitivity (e.g., POTS, 
2004) and convergent and discriminant validity (Scahill et al., 1997; Storch et al., 2004b).  CY-
BOCS-SR scores were entered as a continuous variable.  
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Potential predictors by domain.  Predictors are categorized by the following five 
domains: demographic, treatment history, comorbid symptoms, OCD severity, and OCD 
symptom subtype.   
Demographic.  Age at admission, in years, was recorded at admission and was entered 
into the regression model as a continuous variable.  Gender was recorded at admission and was 
entered into the regression model as a dichotomous categorical variable and dummy coded 
(male = 0, female = 1).  Length-of-stay was a summation of number of days patients were in the 
program from day of admission to day of discharge.  Length-of-stay was entered into the 
regression model as a continuous variable.  
Treatment history.  Treatment history was obtained at admission during the psychiatric 
clinical interview.  A systematic review of the archival data was performed to categorize patients 
who have received various types of treatment prior to presenting for residential admission.  
Types of treatment identified include: outpatient, inpatient, intensive outpatient, partial 
hospitalization or day treatment, and residential.  Each treatment type was entered into the 
regression model simultaneously as separate dichotomous categorical variables and dummy 
coded (having previously received treatment type= 1, not having received treatment type = 0). 
Comorbid symptoms.  Measures of comorbid symptoms were based on the subscales of 
the Screen for Child Anxiety-Related Emotional Disorders, Child Report (SCARED-C; Birmaher et 
al., 1997), total score of the Anxiety Sensitivity Index (ASI; Reiss, Peterson, Gursky, & McNally, 
1968), total score of the Beck Depression Inventory-Second Edition (BDI-II), and the BDI-II 
marker for suicidal ideation (Beck, Steer, Ball, & Ranieri, 1996).  The SCARED-C was developed as 
an instrument to screen the severity of anxiety symptoms in children and adolescents (age 9-18 
years).  It is a 41-item self-report measure divided into five factors: generalized anxiety (9 items), 
separation anxiety (8 items), social phobia (7 items), school phobia (4 items), and panic/somatic 
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symptoms (13 items).   Each item is rated on a 3-point scale based on feelings during the past 3 
months (0 = not true or hardly ever true, 1 = sometimes true, 2 = true or often true). Total 
SCARED-C scores range from 0 to 82, with higher scores reflecting higher levels of anxiety.  
Previous research demonstrates evidence of good psychometric properties, including internal 
consistency and divergent and convergent validity (Birmaher et al., 1997).  The SCARED-C was 
administered at admission and measures overall anxiety symptom severity; symptoms of 
generalized, social, separation, and school anxiety; as well as somatic symptoms associated with 
anxiety at time of admission.  SCARED-C subtest scores were entered as continuous variables 
into the regression analysis.  Table 5 displays the internal consistency (coefficient alpha) for the 
subscales within the SCARED-C and reliability (Cronbach’s alpha) for the current study sample.    
The ASI (Reiss, Peterson, Gursky, & McNally, 1968) is a 16-item self-report measure of 
beliefs and fears of physiological sensations associated with anxiety.  Items are rated on a 5-
point Likert scale (0 = very little, 1 = a little, 2 = some, 4 = much, 5 = very much) with total scores 
ranging from 1 to 64.  Each item describes a possible negative outcome of anxiety symptoms 
and includes three factors: somatic, psychological, and social consequences of anxiety (Zinbarg, 
Barlow, & Brown, 1997).  Reported reliability ranges from .71 to .85 (Peterson, & Heilbronner, 
1987; Reiss et al., 1986).  The ASI composite score was entered as a continuous variable.    
The BDI-II (Beck, Steer, Ball, & Ranieri, 1996) is a 21-item, self-report measure of 
depressive symptoms experienced during the past week.  Items are rated on a 4-point Likert 
scale ranging from 0-3 with higher scores representing greater depressive symptom severity.  
Extensive reliability and validity data have been reported for clinical and non-clinical samples 
(Beck et al., 1996; Storch et al., 2004b).  Reliability coefficients for the BDI-II for adolescent 
psychiatric patients range between .92 and .94 (Krefetz, Steer, Gulab, & Beck, 2002; Kumar, 
Steer, Teitelman, & Villacis, 2002; Steer, Kumar, Ranieri, & Beck, 1998). BDI score was entered as 
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a continuous variable.   The BDI-II also contains a marker for suicidal ideation.  Item 9 on the 
BDI-II asks patients to rate "Suicidal Thoughts or Wishes" and was used as a marker for 
suicidality.  It is noted that the utilization of a single-item question (BDI-II Q9) in measuring a 
construct (suicidality) can elicit problems with reliability.  This variable was entered into the 
regression model as a continuous variable.   
OCD symptom severity. The CY-BOCS-SR, as described above, was administered upon 
admission.  For the proposed study, subscales for obsessions and compulsions were considered 
separately from overall combined symptom score as potential predictors of outcome.  
Composite scores on the CY-BOCS-SR at admission were used as a measure of baseline symptom 
severity and entered into the regression model as continuous variables.  Table 5 displays the 
internal consistency (coefficient alpha) for the subscales within the CY-BOCS-SR and reliability 
(Cronbach’s alpha) for the current study sample.    
OCD symptom subtype.  The CY-BOCS-SR Symptom Checklist was used to categorize 
OCD symptom subtype at baseline.  Based on the four-factor solution presented by Stewart et al. 
(2008) seven categories of obsessions and six categories of compulsions on the CY-BOCS-SR 
were used in creating the following symptom subtypes: 1) symmetry, ordering, repeating, and 
checking (SORC); 2) contamination, cleaning, and aggressive and somatic symptoms (CCAS); 3) 
hoarding obsessions and compulsions (H); and 4) sexual and religious symptoms (SR).  Each was 
entered into the regression analysis as dichotomous variables (0 = no reported symptom, 1 = 
symptom reported at admission).   
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Table 5 
Internal Consistency Reliability Coefficient alphas for all independent variables 
  Number of Number of Reliability Current Sample 
  Participants Items Coefficient (Cronbach’s α) 
        
SCARED-C 178 41 .89 - .91 .96 
 SCARED-Panic  81 13 .70 - .92 .92 
 SCARED-GAD 88 9 .71 - .78 .89 
 SCARED-SAD 86 8 .54 - .86 .87 
 SCARED-SoAD 86 7 .75 - .89 .89 
 SCARED-SA 85 4 .43 - .76 .80 
ASIa 195 -- .75 - .85 -- 
BDI-IIa 129 -- .92 - .94 -- 
OCD Severity 196 10 .87 - .90 .80 
 Obsessions 196 5 .78 - .81 .70 
 Compulsions 196 5 .78 - .81 .70 
Note.  SCARED-C=composite SCARED score; SCARED-Panic=panic or somatic symptoms; SCARED-
GAD=generalized anxiety; SCARED-SAD=separation anxiety; SCARED-SoAD=social anxiety; SCARED-SA= 
school avoidance; ASI=anxiety sensitivity index, BDI-II=Beck Depression Inventory  
a
 Item analysis was not available in the archival data. 
Table 5 displays the internal consistency for the subscales of the SCARED-C, ASI, BDI, and 
CY-BOCS-SR as well as the reliability coefficients for the current sample.  Reliability is moderate 
to high for the SCARED-C (internal consistency reliability coefficient = .43-.92) and was found to 
be high for the current sample (Cronbach’s alpha = .80-.96).  Reliability is high for the CY-BOCS-
SR (internal consistency reliability coefficient = .78-.81) and was found to be high for the current 
sample (Cronbach’s alpha = .70).  This level indicates a moderate to high level of consistency of 
the items within each subscale.   Reliability is also high for the ASI and BDI-II is reported (internal 
consistency reliability coefficients = .75-.85 and .92-.94 respectively), but was not available for 
this sample as individual items were not available in the archival data set.  The number of items 
of each scale is included to aid in interpretation of alpha.  Scales can appear more homogeneous 
(increased alpha) by adding items which may artificially inflate composite scores of instruments 
measuring distinct attributes. 
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Data Analysis.  Preliminary analyses were conducted to evaluate intercorrelations 
among independent variables and correlations between all independent variables and the 
outcome measure.  Chi-square and t-tests were conducted to identify statistically significant 
differences and to check for independence between variables.  Finally, a paired samples t-test 
was conducted to identify statistically significant differences between of patient scores on the 
CY-BOCS-SR from admission to discharge.   
Separate standard multiple regression analyses were run by domain to assess the ability 
of each set of independent variables to predict patient outcome (CY-BOCS-SR score at discharge) 
in order to address research Question 1: What is the relationship of potential predictors by 
domain (demographic, treatment history, comorbid symptoms, OCD symptom severity, and OCD 
symptom subtype) to treatment outcome?    All IVs within each domain were entered 
simultaneously to determine the predictive validity accounted for by the domain.  R2 was 
examined in each model to determine what percentage of the variance in treatment outcome is 
explained by the model.  Each independent variable was then evaluated for its overall 
contribution to the prediction of treatment outcome.  Standardized coefficients (Beta) were 
inspected to determine the variable with the largest coefficient.  Significance was determined 
based on α = .05.  This indicated which variable in the domain made a significant unique 
contribution to explaining treatment outcome when variances from all other potential 
predictors in the model are controlled.  Additionally, the semipartial correlation coefficient was 
squared to determine how much of the total variance in treatment outcome was uniquely 
explained by the variable.  Due to the potential for independent variables to be moderately 
correlated, it is necessary to determine unique contribution with shared variance removed from 
the model.  This resulted in five (demographic, treatment history, comorbid symptoms, OCD 
severity, OCD symptom subtype) separate regression analyses. 
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Separate hierarchical regression analyses were planned in order to answer research 
Question 2: How much improvement in prediction of treatment outcome is associated with the 
addition of identified predictors to OCD symptom severity at admission?  No models from 
Question 1 were found to significantly predict treatment outcome thus research Question 2 was 
irrelevant.  It was hypothesized that elimination of inpatient treatment from the treatment 
history model could increase predictive validity of the model.  The following research questions 
were developed in order to further investigate results of research Question 1: (a) Can the 
prediction of treatment outcome by treatment history be improved by elimination of inpatient 
hospitalization from the regression model? and (b) If, with inpatient hospitalization removed, 
treatment history is found to significantly predict treatment outcome, what is the ability of this 
model to then predict treatment outcome at discharge, controlling for OCD symptom severity 
(CY-BOCS-SR composite) at admission?  A standard multiple regression analysis was run to 
assess the ability of treatment history with the removal of inpatient hospitalization to predict 
patient outcome (CY-BOCS-SR score at discharge).  R2 was examined to determine what 
percentage of the variance in treatment outcome was explained by the model.  In order to 
answer research Question 2b, a hierarchical multiple regression analysis was used to assess the 
ability of previous treatment to predict OCD symptoms at discharge, after controlling for the 
influence of CY-BOCS-SR scores at admission.  Baseline symptoms severity (CY-BOCS-SR) was 
entered into the first block of the regression followed by treatment history into the second 
block. R2 was examined in the second block of the model to determine what percentage of the 
variance in treatment outcome was explained by the addition of treatment history to baseline 
severity.  To determine how much additional variance in treatment outcome is explained by the 
predictor(s) in the second block above and beyond symptom severity, R2 change scores were 
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examined and checked for significance.  The significant unique contribution of each predictor 
was evaluated by examining the standardized coefficients (Beta).   
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CHAPTER 4: Results 
 The following are results from the present study.  The Statistical Package for the Social 
Sciences (SPSS 22 for Windows) program was used to conduct the statistical analyses for this 
study.  Results are organized as follows:  (1) preliminary analyses including correlations, t-tests, 
and Chi-square tests of data; (2) standard multiple regression for research question 1; and (3) 
hierarchical multiple regression analyses for research question 2.   
Preliminary Analyses 
Correlational analyses were performed using Pearson Product-moment correlation 
coefficients and Spearman rho to examine the relationships between independent variables and 
independent variables and the outcome variable.  Intercorrelations between the independent 
variables were computed to check for a high relation between predictors because this would 
result in a biased estimation of regression statistics (i.e., collinearity).  Intercorrelations, 
presented in Table 6, suggest a wide range of relationships among continuous independent 
variables.   The intercorrelations among SCARED-C and SCARED-Panic (r = .861), SCARED-C and 
SCARED-GAD (r = .867), SCARED-GAD and SCARED-SA (r = .737), SCARED-Panic and BDI-II (r 
= .754), SCARED-GAD and BDI-II (r = .764), SCARED-SA and BDI-II (r = .721), CY-BOCS-SR and 
Obsessions (r = .869), and Obsessions and Compulsions (r = .875) suggest a strong relationship 
among these variables.  Due to the violation of the assumption of multicollinearity (VIF > 10), 
only the SCARED-C composite was entered into the regression model.    
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Table 6 
Intercorrelations among Continuous Variables 
  2 3 4 5 6 7 8 9 10 11 
SCARED-C .861** .867** .792** .715** .808** .727** .727** .325** .220** .307** 
2. SCARED-Panic   .669** .610** .443** .588** .537** .754** .171 .067 .134 
3. SCARED-GAD   .567** .561** .737** .629** .764** .235** .151 .247* 
4. SCARED-SAD    .438** .560** .581** .446* .307** .069 .210 
5. SCARED-SoAD     .600** .447** .583** .241* .037 .154 
6. SCARED-SA      .574** .721** .359** .105 .258* 
7. ASI       .578** .341** .212** .307** 
8. BDI-II        .413** .312** .421** 
9. CY-BOCS-SR Admit        .544** .869** 
10. Obsessions          .875** 
11. Compulsions 
Note.  SCARED-C=composite SCARED score; SCARED-Panic=panic or somatic symptoms; SCARED-
GAD=generalized anxiety; SCARED-SAD=separation anxiety; SCARED-SoAD=social anxiety; SCARED-SA= 
school avoidance; ASI=anxiety sensitivity index, BDI-II=Beck Depression Inventory  
*p<.05, **p<.01 
Correlations between independent variables and the outcome measure (CY-BOCS-SR) 
are presented in Table 7.  Inspection of the relationships between independent variables and 
the outcome measure reveal statistically significant correlations between length-of-stay (r 
= .219), SCARED-C (r = .119), CY-BOCS-SR (r =.176), CY-BOCS-SR obsession subtest (r = .314), CY-
BOCS-SR compulsion subtest (r = .279), and hoarding symptoms (r = -.244).  Results indicate 
higher scores on the SCARED-C, CY-BOCS-SR composite, obsession subtest, and compulsion 
subtest are associated with higher CY-BOCS-SR scores at discharge.  Conversely, endorsement of 
hoarding symptoms on the CY-BOCS-SR Symptom Checklist at admission was correlated with 
lower CY-BOCS-SR scores at discharge.  Inspection of correlation coefficients indicate a longer 
length-of-stay was associated with higher CY-BOCS-SR scores at discharge.  This finding should 
be interpreted with caution considering the variability of this variable in this intent-to-treat 
sample.   
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Table 7 
 
Correlations between Independent Variables and Outcome Measure 
  Discharge CY-BOCS-SR 
 1. Age .063 
 2. Gender .060 
 3. Length-of-stay .219** 
 4. Outpatient .098 
 5. Inpatient .058 
 6. IOP .100 
 7. PHP .150 
 8. Res .125 
 9. SCARED-C .119** 
 10. ASI .135 
 11. BDI-II .168 
 12. BDI-II Q9 .162 
 13. CY-BOCS-SR Admit .176* 
 14. Obsessions .314** 
 15. Compulsions .279** 
 16. SORC -.217 
 17. CCAS -.100 
 18. H -.244* 
 19. SR -.107 
Note.  IOP=intensive outpatient program; PHP=partial hospitalization or day treatment program; 
Res=residential treatment; SCARED-C=composite SCARED score; ASI=anxiety sensitivity index, BDI-II=Beck 
Depression Inventory; BDI-II Q9=suicidality marker on the BDI-II; SORC=symmetry, ordering, repeating, 
and checking; CCAS=contamination, cleaning, and aggressive and somatic symptoms; H=hoarding 
obsessions and compulsions; SR=sexual and religious symptoms  
*p<.05, **p<.01 
As shown in Table 8 chi-square tests for independence (with Yates Continuity Correction) 
indicated no significant association between gender and history of outpatient treatment (χ2 (1,  
n = 137) = .15, p = .703, phi = -.058), intensive outpatient treatment (χ2 (1, n = 137) = .00, p = 
1.00, phi = -.014), partial or day treatment( χ2 (1, n=137) = 2.21, p = .137, phi = .147), or previous 
residential treatment χ2 (1, n = 137) = .121, p = .728, phi = .050).  A significant association was 
found between gender and previous inpatient treatment χ2 (1, n = 137) = 7.14, p = .008, phi 
= .243) indicating, in the current sample, a significantly greater proportion of females (n = 33, 
49.3%) had received inpatient treatment when compared to males (n = 18, 25.7%).  Chi-square 
tests for independence revealed no significant association between gender and presentation by 
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symptom subtype at admission (CCAS, χ2 (1, n = 84) = .110, p =.204, phi = -.138; H, χ2 (1, n = 84) 
= .026, p = .873, phi = -.046; SR, χ2 (1, n = 84) = .026, p = .873, phi = -.046).  Results of the 
association of subtype SORC were not reported due to the violation of minimum expected cell 
frequency (at least 80% of cells must have expected frequencies of 5 or more) (Pallant, 2007).  
This violation occurred as a result of the high rate of endorsement of symptoms by both males 
(yes, n = 45; no, n = 2) and females (yes, n = 37; no, n = 0) on this symptom subtype.    
Table 8 
Clinical Characteristics: Chi-square Tests for Independence Total Sample and Comparisons 
between Genders 
  Total sample Males Females  χ2 p 
  (n=196) (n= 99) (n=97)    
Treatment History  
 Outpatient 125(63.8) 65(33.2) 60(30.6) .146[1] .703 
 Inpatient 51(37.2) 18(9.2) 33(16.8) 7.14[1] .008*
 IOP 17(8.7) 9(4.6) 8(4.1) .000[1] 1.000 
 PHP 23(11.7) 8(4.1) 15(6.6) 2.21[1] .137 
 Res 20(10.2) 9(4.6) 11(5.6) .121[1] .728 
OCD Symptom Subtype 
 SORC 82(41.8) 45(23.0) 37(18.9) -- -- 
 CCAS 36(18.4) 23(11.7) 13(6.6) 1.10[1] .204 
 H 84(42.9) 12(6.1) 8(4.1) .026[1] .873 
 SR 20(10.2) 12(6.1) 8(4.1) .026[1] .873 
Note.  Data presented as number of patients (percentage based on overall sample).  Values in square 
brackets indicate degrees of freedom.  IOP=intensive outpatient program; PHP=partial hospitalization or 
day treatment program; Res=residential treatment; SORC=symmetry, ordering, repeating, and checking; 
CCAS=contamination, cleaning, and aggressive and somatic symptoms; H=hoarding obsessions and 
compulsions; SR=sexual and religious symptoms  
*p < .05. 
Independent t-tests were conducted to identify statistically significant differences 
between continuous variables by gender.  Table 9 displays results of t-test analysis.  Results 
indicate that there were no significant mean differences in length of stay (LOS) for males (M = 
78.67, SD = 37.08) and females (M = 74.64, SD = 33.03; t(194) = .802, p = .423).  Results indicate 
that there were no significant mean differences for age at admission for males (M = 15.53, SD = 
1.15) and females (M = 15.31, SD = 1.24; t(194) = 1.26, p = .209).  Subscales of the CY-BOCS-SR 
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indicate higher but non-significant mean differences in obsessions for females (M = 13.05, SD = 
3.16) when compared to males (M = 12.45, SD = 2.74; t(194) = -1.41, p = .159).  Mean 
differences between gender for compulsive symptoms were also non-significant with females 
having slightly higher scores at admission (males M = 12.12, SD = 2.85; females M = 12.82, SD = 
3.14; t(194) = -1.64, p = .102). Finally, no significant mean differences by gender were found for 
composite CY-BOCS-SR scores with females (M = 25.96, SD = 5.56) again having a slightly higher 
composite score at admission compared to males (M = 24.58, SD = 5.03; t(194) = -1.83, p = .069).  
Results did indicate that there were significant mean differences in SCARED-C scores at 
admission for males (M = 29.11, SD = 17.61) and females (M = 38.10, SD = 18.59; t(176) = -3.31, 
p = .001) showing females with significantly higher symptoms of anxiety.  The magnitude of the 
differences in the means (mean difference = -8.99, 95% CI: -14.34 to -3.63) was moderate (eta 
squared = .059).  Significant mean differences were also noted in SCARED-Panic scores at 
admission for males (M = 6.81, SD = 6.83) and females (M = 10.41, SD = 6.75; t(78.7) = -2.39, p 
= .019).  The magnitude of the differences in the means (mean difference = -3.60, 95% CI: -6.61 
to -.59) was moderate (eta squared = .067).  Significant mean differences were noted in SCARED-
GAD scores at admission for males (M = 8.96, SD = 5.16) and females (M = 12.76, SD = 4.85; t(86) 
= -3.56, p = .001).  The magnitude of the differences in the means (mean difference = -3.81, 95% 
CI: -5.93 to -1.68) was moderate (eta squared = .128).  Significant mean differences were also 
noted in SCARED-SAD scores at admission for males (M = 4.02, SD = 3.60) and females (M = 6.78, 
SD = 4.93; t(72.6) = -2.94, p = .004).  The magnitude of the differences in the means (mean 
difference = -2.76, 95% CI: -4.63 to -.89) was moderate (eta squared = .096).  There was no 
significant difference in SCARED-SoAD scores at admission for males (M = 6.07, SD = 4.15) and 
females (M = 7.20, SD = 4.36; t(84) = -1.23, p = .221).  Significant mean differences were also 
noted in SCARED-SA scores at admission for males (M = 2.76, SD = 2.33) and females (M = 4.05, 
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SD = 2.68; t(83) = -2.38, p = .019).  The magnitude of the differences in the means (mean 
difference = -1.29, 95% CI: -2.37 to -.21) was moderate (eta squared = .064).  Significant mean 
differences were also noted in ASI scores at admission for males (M = 17.61, SD = 11.79) and 
females (M = 24.04, SD = 13.92; t(193) = -3.49, p = .001).  The magnitude of the differences in 
the means (mean difference = -6.44, 95% CI: -10.09 to -2.79) was moderate (eta squared = .059).   
Results indicate that there were significant mean differences in BDI-II scores at admission for 
males (M = 16.39, SD = 12.58) and females (M = 25.22, SD = 12.77; t(127) = -3.95, p < .001).  The 
magnitude of the differences in the means (mean difference = 2.23, 95% CI: -13.24 to 4.41) was 
moderate (eta squared = .110).  Finally, results revealed no significant mean differences in BDI-
IIQ9 scores at admission for males (M = .61, SD = .79) and females (M = .97, SD = .91; t(60) = -
1.67, p = .100).  The magnitude of the differences in the means (mean difference = -.36, 95% CI: -
-.79 to .07) was moderate (eta squared = .044).  Overall, females reported higher symptoms of 
anxiety and depression at admission when compared to their male counterparts, with the 
exception of social anxiety and suicidal ideation which were not significant differences but did 
show higher scores for female patients.   
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Table 9 
 
Clinical Characteristics: t-Tests for Total Sample and Comparisons between Genders 
  Total sample Males Females t p 
  (N=196) (n= 99) (n=97)    
LOS   78.67±37.08 74.64±33.03 .80[194] .423 
Age, years  15.52±1.15 15.31±1.24 1.26[194] .209 
Cormorbid Symptoms  
 SCARED-C n=178 29.11±17.61 38.10±18.59 -3.31[176] .001* 
 SCARED-Panic   6.81±6.83 10.41±6.75 -2.38[79] .020* 
 SCARED-GAD  8.96±5.16 12.76±4.85 -3.56[86] .001* 
 SCARED-SAD  4.02±3.60 6.78±4.93 -2.94[84] .004* 
 SCARED-SoAD  6.07±4.15 7.20±4.36 -1.23[84] .221 
 SCARED-SA  2.76±2.33 4.05±2.68 -2.38[83] .019* 
 ASI n=195 17.60±11.79 24.04±13.92 -3.48[193] .001* 
 BDI-II n=129 16.39±12.58 25.22±12.78 -3.95[127] .000* 
 BDI-II Q9 n=62 .61±.79 .97±.91 -1.671[60] .100 
OCD Severity n=196 24.58±5.03 25.96±5.56 -1.83[194] .069 
 Obsessions  12.45±2.74 13.05±3.16 -1.41[194] .159 
 Compulsions  12.12±2.85 12.82±3.14 -1.64[194] .102 
Note.  Data presented as mean ± SD.  Values in square brackets indicate degrees of freedom.  LOS=length 
of stay; IOP=intensive outpatient program; PHP=partial hospitalization or day treatment program; 
Res=residential treatment; SCARED-C=composite SCARED score; SCARED-Panic=panic or somatic 
symptoms; SCARED-GAD=generalized anxiety; SCARED-SAD=separation anxiety; SCARED-SoAD=social 
anxiety; SCARED-SA= school avoidance; ASI=anxiety sensitivity index; BDI-II=Beck Depression Inventory; 
BDI-II Q9=suidicality marker on the BDI-II  
*p < .05. 
A paired samples t-test was conducted to identify statistically significant differences 
between of patient scores on the CY-BOCS-SR from admission to discharge.  There was a 
statistically significant decrease in OCD symptom severity from admission (M = 24.98, SD = 5.19) 
to discharge (M = 12.74, SD = 7.65), t(179) = 20.63, p < .001).  The mean decrease in CY-BOCS-SR 
scores was 12.23 with a 95% confidence interval ranging from 11.06 to 13.40.  The eta squared 
statistic indicated a large effect size (eta squared = .70).  
Table 10 
Paired Samples t-Test CY-BOCS-SR Scores Admission to Discharge 
  M SD t p  
        
 Admit CY-BOCS-SR 24.98 5.19 20.63 .000** 
 Discharge CY-BOCS-SR 12.74 7.65  
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Data Analysis 
All additional data screening required to meet appropriate statistical assumptions for 
analyses were performed including: outliers, normality, linearity, homoscedasticity, and 
independence of residuals.   In order to explore potential predictors, standard and hierarchical 
regression procedures were planned to determine the predictive validity accounted for by each 
set of independent variables.  Methods are outlined based on research questions. 
Question 1.  In order to address research question 1a-e, separate standard multiple 
regression analyses were run by domain to assess the ability of each set of independent 
variables to predict patient outcome (CY-BOCS-SR score at discharge).  All IVs within each 
domain were entered simultaneously to determine the predictive validity accounted for by the 
domain.  Each independent variable was then evaluated for its overall contribution to the 
prediction of treatment outcome.  Due to the high-to-moderate intercorrelations amongst some 
independent variables, semipartial correlation coefficients were squared to determine unique 
contribution of each variable with shared variance removed from each model. 
Table 11 
 
Standard Regression Analysis Demographics Predicting Treatment Outcome  
  B SE B β p R2  
        
Model 1:     .061* 
 (Constant) -1.433 7.705  .853 
 Age, years .558 .467 .088 .233   
 Gender 1.202 1.122 .079 .285 
 Length-of-stay .049 .016 .226 .002** 
*p<.05, **p<.01  
Displayed in Table 9, a standard multiple regression analysis was conducted to evaluate 
how well demographic variables predicted treatment outcome (CY-BOCS-SR score at discharge).  
The overall model explained 6.1% of the variance of treatment outcome and was statistically 
significant, F (3,176) = 3.793, p = .011.   Length-of-stay was found to make the strongest and 
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statistically significant unique contribution to explaining treatment outcome when controlling 
for all other variables (β = .226, p = .002).   Further examination of beta statistics revealed 
greater length-of-stay was associated with greater symptom severity at discharge. Neither age 
nor gender emerged as significant predictors of treatment outcome within the model. Analysis 
of semipartial correlation coefficients revealed length-of-stay uniquely explains 5% of the 
variance in treatment outcome.  The contribution of age and gender was negligible.    
Table 12 
 
Standard Regression Analysis Treatment History Predicting Treatment Outcome  
  B SE B β p R2  
        
Model 2:     .075 
 (Constant) 8.860 2.418  .000 
 Outpatient 2.739 2.394 .102 .255  
 Inpatient -.255 1.415 -.014 .874 
 IOP 2.636 2.064 .114 .204 
 PHP 4.007 1.760 .196 .024* 
 Res 3.212 1.942 .149 .101 
Note.  IOP=intensive outpatient program; PHP=partial hospitalization or day treatment program; 
Res=residential treatment 
*p<.05, **p<.01  
In order to evaluate how well treatment history predicted treatment outcome (CY-
BOCS-SR score at discharge) a standard multiple regression analysis was conducted (see Table 
10).  The linear combination of outpatient, inpatient, IOP, PHP, and residential treatment 
explained 7.5% of the variance of treatment outcome but was not significantly related to 
treatment outcome, F (5,127) = 2.054, p = .075.   A history of PHP treatment was found to make 
the strongest and statistically significant unique contribution to explaining treatment outcome 
when controlling for all other treatment types (β = .196, p = .024).   Further examination of beta 
statistics revealed patients who had received inpatient treatment prior to residential admission 
were more likely to have lower symptom severity at discharge whereas history of other types of 
treatment was associated to higher OCD severity at discharge.   Analysis of semipartial 
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correlation coefficients revealed that outpatient uniquely explains 1%, IOP uniquely explains 1%, 
PHP uniquely explains 4%, and residential uniquely explains 2% of the variance in treatment 
outcome respectively.  The contribution of having a history of inpatient treatment was negligible.    
Table 13 
 
Standard Regression Analysis Comorbid Symptoms Predicting Treatment Outcome  
  B SE B β p R2 
        
Model 3:     .041 
 (Constant) 9.920 2.318  .000 
 SCARED-C .074 .101 .181 .466 
 ASI -.016 .120 -.027 .897 
 BDI-II .035 .153 .061 .820  
 BDI-II Q9 -.103 1.918 -.012 .957 
*p<.05, **p<.01  
Results of a standard multiple regression analysis to evaluate how well comorbid 
symptoms are presented in Table 11.  The linear combination of scores on the SCARED-C, ASI, 
BDI-II, and indicator for suicidality (BDI-II Q9) explained 4.1% of the variance of treatment 
outcome but was not significantly related to treatment outcome, F (4, 48) = .517, p = .724.   An 
inspection of individual predictors revealed that scores on the SCARED-C were found to make 
the strongest unique contribution to explaining treatment outcome when controlling for all 
other scales; this was not a statistically significant contribution (β = .181, p = .466).   An 
examination of beta statistics revealed higher SCARED-C scores and BDI-II scores at admission 
was associated with greater symptom severity at discharge whereas higher ASI scores and 
greater suicidality was associated with lower reported OCD severity at discharge.   Analysis of 
semipartial correlation coefficients revealed that SCARED-C uniquely explains 1% of the variance 
in treatment outcome.  All other variables contribution was negligible.    
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Table 14 
 
Standard Regression Analysis OCD Severity at Admission Predicting Treatment Outcome  
  B SE B β p R2 
        
Model 4:     .032*  
 (Constant) 6.885 2.492  .006 
 Obsessions .460 .190 .178 .017*  
  B SE B β p R2 
        
Model 5:     .099**  
 (Constant) 2.793 2.319  .230 
 Compulsions .798 .181 .314 <.001**  
  B SE B β p R2 
        
Model 6:     .099**  
 (Constant) 2.635 2.680  .327 
 Obsessions .026 .373 .010 .906 
 Compulsions .784 .216 .309 <.001**  
  B SE B β p R2 
        
Model 7:     .078**  
 (Constant) 2.616 2.665  .328 
 CY-BOCS-SR .401 .103 .279 <.001** 
*p<.05, **p<.01  
In order to investigate how well OCD symptom at admission was able predict treatment 
outcome at discharge separate standard multiple regression analyses (Table 12) were 
performed.  Variables were entered into regression models separately and together to 
determine predictive validity of each combination of this measure.  Variance inflation factor (VIF) 
was calculated to test for multicollinarity of the subtests due to high correlations and were 
found to be acceptable (VIF = 1.42).  Results of the first standard regression (Model 4) indicate 
the obsessions subtest of the CY-BOCS-SR explained 3.2% of the variance of treatment outcome 
and was significantly related to outcome scores F (1, 178) = 5.83, p = .017.    Results of the 
second standard regression (Model 5) indicate the compulsions subtest of the CY-BOCS-SR 
explained 9.9% of the variance of treatment outcome and was significantly related to outcome 
scores F (1, 178) = 19.490, p < .001.  The linear combination of obsessions and compulsions was 
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found to explain 9.9% of the variance of treatment outcome and was significantly related to 
treatment outcome, F (2, 179) = 9.698, p < .001.  An inspection of individual predictors in Model 
6 revealed that compulsion subtest scores made the strongest and statistically significant unique 
contribution to explaining treatment outcome when controlling for the obsession subtest (β 
= .309, p < .001).   Analysis of semipartial correlation coefficients revealed that compulsion 
subtest scores uniquely explain 6.7% of the variance in treatment outcome.  The contribution of 
the obsession subtest was negligible.   Results of the fourth standard regression (Model 7) reveal 
CY-BOCS-SR composite scores explained 7.8% of the variance of treatment outcome and was 
also significantly related to outcome scores F (1, 179) = 15.081, p < .001.  Analyses of beta 
statistics revealed higher scores on subtests and the composite CY-BOCS-SR at admission was 
related to higher reported OCD severity at discharge. 
Table 15 
 
Standard Regression Analysis Symptom Subtype Predicting Treatment Outcome 
  B SE B β p R2 
        
Model 8:     .120 
 (Constant) 24.504 6.267  <.001 
 SORC -11.044 6.165 -.221 .078  
 CCAS .155 2.954 .010 .958   
 H -4.578 2.735 -.256 .099   
 SR .190 2.735 .011 .069   
Note. SORC=symmetry, ordering, repeating, and checking; CCAS=contamination, cleaning, and aggressive 
and somatic symptoms; H=hoarding obsessions and compulsions; SR=sexual and religious symptoms 
*p<.05, **p<.01  
 Table 13 displays the final standard multiple regression analysis that was conducted to 
evaluate how well OCD symptom subtype predicted treatment outcome (CY-BOCS-SR score at 
discharge).  The linear combination of SORC, CCAS, H, and SR explained approximately 12% of 
the variance of treatment outcome, and although explained more variance than any of the other 
regression models, was not significantly related to treatment outcome, F (4, 70) = 2.383, p 
= .060.   Hoarding symptoms made the strongest unique contribution (β = -.256) to explaining 
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treatment outcome when controlling for all other symptom type, but was not a statistically 
significant unique contribution.  An examination of beta statistics revealed patients endorsing 
SORC and hoarding symptoms at admission reported lower symptom severity at discharge 
whereas patients reporting symptoms of CCAS and SR at admission were likely to report higher 
OCD severity at discharge.   Analysis of semipartial correlation coefficients revealed that OCD 
symptom subtypes which includes symmetry, ordering, repeating, and checking (SORC) and 
hoarding (H) each uniquely explains 4% of the variance in treatment outcome.  All other 
variables contribution was negligible.    
Question 2.  In order to address research Question 2a, as all other models under 
Question 1 revealed non-significant prediction models, a hierarchical regression analysis was 
conducted to determine the ability of demographic variables (age, gender, length-of-stay) to 
predict treatment outcome at discharge, controlling for OCD symptom severity at admission. 
Also, the investigation of treatment history as a potential predictor in Question 1b revealed, 
with all variables included in the model, explained 7.5% of the variance in treatment outcome.  
A history of PHP treatment was the only variable among potential predictors to make a 
significant unique contribution to the regression model.  It is hypothesized that elimination of 
inpatient treatment from the model could increase predictive validity of the model.  First, 
patients who have received inpatient treatment typically display a level of psychiatric acuity 
different from patients receiving the other types of treatment.  The very nature of inpatient 
hospitalization is to serve individuals who have the inability to keep themselves or others 
around them safe whereas this is frequently exclusionary criteria for the other levels of 
treatment included in the model.  Also, a history of inpatient hospitalization was found to make 
the lowest unique contribution to explaining treatment outcome when controlling for all other 
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treatment types (β = -.014, p = .874).  The following research questions were developed in order 
to further investigate results:  
a) Can the prediction of treatment outcome by treatment history be improved by 
elimination of inpatient hospitalization from the regression model?  
b) If, with inpatient hospitalization removed, treatment history is found to significantly 
predict treatment outcome, what is the ability of this model to then predict treatment 
outcome at discharge, controlling for OCD symptom severity (CY-BOCS-SR composite) at 
admission? 
Table 16 
 
Hierarchical Regression Analysis Predicting Treatment Outcome by Demographic Variables 
(Model 1) Controlling for Baseline Symptom Severity 
  B SE B β R2 Δ R2 
        
Model ##: 
Step 1:    .078** 
 (Constant) 2.616 3.107 
 CY-BOCS-SR  .401 .120 .279** 
Step 2:    .119** .041* 
 (Constant) -8.407 7.762    
 CY-BOCS-SR .353 .104 .246** 
 Age .526 .454 .083 
 Gender .674 1.101 .044 
 Length-of-stay .041 .016 .187*    
*p<.05, **p<.01 
CY-BOCS-SR composite admission scores were entered into Step 1, explaining 7.8% of 
the variance in CY-BOCS-SR scores at discharge.  After entry of previous treatment in Step 2, the 
total variance explained by the model as a whole was 11.9% F(4, 175) = 5.891, p < .001.  
Demographic variables explained an additional 4.1% of the variance in CY-BOCS-SR discharge 
scores, after controlling for CY-BOCS-SR admission scores, R squared change = .041, F change (3, 
175) = 2.684, p = .048.  The final model revealed that a length-of-stay was found to make the 
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strongest and statistically significant unique contribution to the model when controlling for all 
other treatment types and symptom severity at admission (β = .178, t = 2.604, p = .010).    
Table 17 
Standard Regression Analyses Treatment History, Excluding Inpatient, Predicting Treatment 
Outcome  
  B SE B β p R2  
        
Model 9:     .075* 
 (Constant) 8.801 2.380  .000 
 Outpatient 2.732 2.385 .101 .254  
 IOP 2.649 2.054 .115 .200 
 PHP 3.971 1.739 .195 .024* 
 Res 3.121 1.849 .145 .094 
Note.  IOP=intensive outpatient program; PHP=partial hospitalization or day treatment program; 
Res=residential treatment 
*p<.05, **p<.01  
In order to investigate the ability of treatment history, with inpatient hospitalization 
removed, to predict treatment outcome a standard regression model was conducted (see Table 
14).  The linear combination of treatment history with inpatient hospitalization removed 
continued to explain 7.5% of the variance of treatment outcome but was now found to 
significantly predict treatment outcome, F (4,128) = 2.581, p = .040.   Again, a history of PHP 
treatment was found to make the strongest and statistically significant unique contribution to 
the model when controlling for all other treatment types (β = .195, p = .024).   This indicates that 
inclusion of inpatient hospitalization into the original regression model did not contribute to 
predictive validity of the model.  Thus for patients in this sample having received inpatient 
hospitalization prior to admission to the residential program is not an important piece of 
information in predicting treatment outcome as measured by OCD symptom severity.  
With the exclusion of inpatient hospitalization, treatment history was found to 
significantly predict treatment outcome but the amount of variance explained did not change 
(R2=.075).  In order to answer research Question 2b, a hierarchical multiple regression analysis 
64 
 
 
 
was used to assess the ability of previous treatment (Model 9) to predict OCD symptoms at 
discharge (CY-BOCS-SR), after controlling for the influence of CY-BOCS-SR scores at admission 
(see Table 14).  Composite CY-BOCS-SR scores were chosen as a control despite the variability in 
predictive validity in composite score and individual subtests found in previous regression 
models.  The composite CY-BOCS-SR was chosen to provide a consistent control since the 
dependent measure is composite CY-BOCS-SR scores. 
Table 18 
 
Hierarchical Regression Analysis Predicting Treatment Outcome by Treatment Type (Model 9) 
Controlling for Baseline Symptom Severity 
  B SE B β R2 Δ R2 
        
Model 10: 
Step 1:    .078** 
 (Constant) 2.616 3.107 
 CY-BOCS-SR  .401 .120 .279** 
Step 2:    .170** .092* 
 (Constant) -3.028 3.828    
 CY-BOCS-SR .448 .117 .312** 
 Outpatient 3.125 2.269 .116 
 IOP 2.888 1.954 .125 
 PHP/Day 4.757 1.666 .223*  
 Res 3.023 1.758 .140   
*p<.05, **p<.01 
CY-BOCS-SR composite admission scores were entered into Step 1, explaining 7.8% of 
the variance in CY-BOCS-SR scores at discharge.  After entry of previous treatment in Step 2, the 
total variance explained by the model as a whole was 17% F(5, 132) = 5.220, p < .001.  Prior 
treatment explained an additional 9.2% of the variance in CY-BOCS-SR discharge scores, after 
controlling for CY-BOCS-SR admission scores, R squared change = .092, F change (4, 127) = 3.536, 
p = .009.  The final model revealed that a previous history of PHP was found to make the 
strongest and statistically significant unique contribution to the model when controlling for all 
other treatment types and symptom severity at admission (β = .223, t = 2.856, p = .005).     
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CHAPTER 5: Discussion 
This chapter will review the present investigation and examine results to develop 
meaningful explanations and interpretations relevant to both clinical practice and future 
research.  Finally, the strengths and limitations of the study will be discussed.   
Review of the Study 
The present study sought to investigate potential predictors of treatment outcome in a 
population of adolescent patients receiving treatment in a unique residential setting.  
Participants included 196 adolescents with primary diagnosis of OCD who received treatment 
during January 2009 and May 2014 at the Child and Adolescent Center at Rogers Memorial 
Hospital.  Patients were administered treatment outcome measures at admission and again at 
discharge.  The primary measures used were the Children’s Yale-Brown Obsessive Compulsive 
Scale, self-report (CY-BOCS-SR), CY-BOCS-SR Symptom Checklist, Beck Depression Inventory 
(BDI-II), Anxiety Sensitivity Index (ASI), and the Screen for Child Anxiety-Related Emotional 
Disorders – Child Report (SCARED-C).  Factors with potential associations with treatment 
outcomes were divided into five relevant domains (demographic, treatment history, comorbid 
symptoms, OCD severity, and OCD symptom subtype) and standard regression analyses were 
conducted to explore potential for predictability.  Only one (symptom severity) of the five 
domains investigated revealed models that significantly predicted treatment outcome.  An 
additional hypothesis was posed and explored to improve the predictive validity of treatment 
history for treatment outcome.   
Interpretation of Results and Recommendations for Future Research and Practice 
Response rates of adolescent patients in residential treatment have been reported 
between 64-70% (Bjorgvinsson et al., 2008; Leonard et al., 2014) however the literature 
examining predictors of combined treatment outcomes for pediatric patients with OCD is 
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limited.  The current study sought to investigate potential predictors in a heterogeneous 
population of adolescents receiving treatment in an intensive residential treatment setting.  No 
clear statistical evidence exists providing strong support for the predictability of treatment 
outcome for pediatric OCD.  Consistent with the literature, baseline symptom severity was the 
strongest predictor of treatment outcome in the current sample.  A contribution to the 
literature was the investigation of treatment history as a potential predictor of treatment 
outcome.  As previously stated many factors were included that have been found to be 
inconclusive previously in the literature but were determined important to include due to the 
exclusivity of the population being investigated.   
Predictors of Treatment Outcome 
Demographics.  In this clinical sample, demographic variables significantly predicted 
treatment outcome.  Specifically, length-of-stay was found to significantly predict higher OCD 
severity at discharge while neither age nor gender emerged as significant predictors of 
treatment outcome within the model.  Previous studies investigating the ability of demographic 
variables such as age and gender to predict outcome in similar populations have reported 
inconsistent results (Ginsburg et al., 2008).  Females reported higher anxiety and depression and 
were significantly more likely to have received inpatient hospitalization prior to admission when 
compared to their male counterparts.  It is possible demographic characteristics interact with 
other factors but were not observed with the current statistical investigation.   
The average length-of-stay for the current sample was similar to other investigations of 
residential treatment for adolescent patients with OCD (Bjorgvinsson et al., 2008; Leonard et al., 
2014).  The positive correlation between length-of-stay and OCD severity at discharge is 
surprising assuming increased time in treatment would ameliorate symptoms.  The relationship 
between length-of-stay and outcome could be related to several variables.  The contribution of 
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additional factors such as decreased level of functioning, more comorbid diagnoses, or lack of 
motivation could contribute to a longer length-of-stay.  A patient who lacks motivation for 
change may stay in treatment despite willingness to actively engage in treatment designed to 
lessen symptoms.  The literature suggests clinically significant improvement does not necessarily 
increase as a function of treatment sessions, which may speak to decreased patient investment 
in treatment over time (Barkham et al., 2006).  Also, patients in the current sample may have 
demonstrated psychological or functional improvements not captured by the CY-BOCS-SR at 
discharge.  Finally, this was an intent-to-treat sample who was largely dependent on a third 
party funding for access to a very costly treatment.  Some patients may have left the program 
endorsing severe OCD symptoms but lacked the resources to continue treatment.  Due to the 
scarcity of adolescent residential treatment centers for OCD, there is very little empirical 
evidence to predict what type of patient will seek out such intensive intervention.   It would be 
worthwhile to investigate the differences in characteristics of the current patient sample against 
adolescents receiving non-residential treatment.    
Treatment history.  To this author’s knowledge, this is the first study to investigate 
previous treatment type as a predictive factor of OCD treatment outcome in a residential setting 
making it difficult to compare this current finding to existing literature.  It is interesting that the 
removal of inpatient treatment into the treatment history model significantly predicted 
treatment outcome in residential treatment even after controlling for OCD severity at admission 
(CY-BOCS-SR).  It could be possible that patients, in the current sample, who have a history of 
inpatient treatment, and who have experienced a higher level of psychiatric acuity, are 
systematically different from patients receiving the other types of treatment, thus contributing 
to the current results. While a history of inpatient hospitalization at admission may not 
contribute to predictability of OCD symptom severity at discharge in the current program, it is 
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hypothesized patients with primary diagnosis of OCD who have a history of inpatient 
hospitalization may have notable differences from other patients that deserve further 
investigation.  It is also possible that despite differences in patient experience prior to admission 
to the residential program, components of the current program buffer these differences 
reducing power to predict symptom severity at discharge. 
A history of partial hospitalization or day treatment continued to make the strongest 
and statistically significant unique contribution to each model even when controlling for all 
other treatment types and symptom severity at admission.  This finding is interpreted with 
caution as there is likely shared variance among the variables included in the final model.  As 
previously mentioned, it is not uncommon for individuals who present for residential treatment 
to have extensive history of treatment failure (as reported by parents and previous treatment 
providers upon admission).  One possible explanation for the contribution of PHP might be that 
individuals who seek intensive treatment are experiencing significantly greater functional 
impairments (Piacentini, Bergman, Keller, & McCracken, 2003; i.e. ,conflict with caregivers, poor 
ADLs, inability to attend school, poor or no social interactions) compared to individuals receiving 
outpatient treatment.  Although the CY-BOCS-SR includes questions about time occupied and 
interference in one’s daily life, these items may not contribute enough robustness to capture 
the level of functional impairment characterized in patients seeking residential treatment.  The 
functional impairment of the sample might explain why, even when all other treatment types 
and symptom severity was controlled, history of PHP treatment continued to predict outcome.  
Patients with high CY-BOCS-SR scores who have not received PHP treatment might be those 
patients who, despite severe OCD, do not have as significant functional impairments as those 
who seek more intensive (PHP) treatment.  In other words, it is possible that individuals with 
greater functional impairment seek out more intense programs which may be one explanation 
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to the predictive validity of PHP in this study. It may also be useful to investigate whether overall 
functional impairment could predict treatment outcome better than symptom severity for 
patients who receive treatment for OCD in this residential setting.  One way to investigate this 
with the current data would be parceling out questions on the CY-BOCS-SR that target 
functionality (questions 1, 2, 6, 7) to determine if reported levels of time occupied and 
interference has greater ability to predict treatment outcome than composite symptom severity. 
Additionally, adding a measure of functional impairment to the battery of assessments 
completed by patients and parents at admission and discharge could specifically target this 
construct for future investigations.   
It could be assumed if patients who receive PHP treatment are subsequently seeking a 
more intense level of treatment (residential), similar factors may exist related to poor treatment 
response (as measured by symptom severity reduction) in either setting.  These factors might 
include motivation, readiness to change, insight, family accommodation, etc.  While there is 
evidence in the literature to support the predictive validity of these types of factors (Merlo, 
Lehmkuhl, Geffeken, & Storch, 2009; Storch et al., 2007) these data are not available for the 
patients in the program investigated in this study.  It would be of benefit to include tools to 
measure constructions like patient readiness for treatment, level of parental accommodation, 
and motivation for treatment to help build treatment plans as well as screen for 
appropriateness for the program. 
Cormorbid symptoms. Measures of symptom comorbidity did not significantly predict 
symptom severity at discharge.   In one sample, symptoms of depression have negatively 
impacted treatment outcome (Storch et al., 2010), however others have not found anxiety or 
depression assessment scores to predict OCD treatment outcome (Barrett, Farrell, Dadds, & 
Boulter, 2005; Flament et al., 1985).  It is possible that gender could serve as a moderating 
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variable in the current patient sample because females reported significantly higher anxiety and 
depression symptoms severity at admission (Maher et al., 2010).  The inability of ancillary 
symptoms to predict outcome may provide support for this treatment setting to demonstrate 
positive outcomes of symptom reduction regardless of secondary symptoms or diagnoses.  The 
nature of the residential program in this investigation may contain protective factors in non-ERP 
treatment components or a combination of ERP and additional treatment components which 
serve to buffer patients from the impact of these additional psychiatric symptoms.   
It has been previously found when symptoms of anxiety and depression have been used 
as predictors for compulsive behaviors alone, both were found to be significant predictors 
(Kirkcaldy et al., 2010).  Noting the predictive validity of compulsion subtest scores on the CY-
BOCS-SR at admission, it would be interesting to investigate whether comorbid symptoms would 
predict severity in compulsive behaviors at discharge.  Also of interest and clinical utility would 
be the investigation of self-report versus parental report of externalizing and internalizing 
symptoms of anxiety or depression.  It is suggested that depressive and anxiety and anxiety may 
create information processing biases or contribute to negative cognitive styles which impact 
self-reported symptoms or impact children’s ability to clearly identify irrational thinking (Beck, & 
Clark, 1997; Storch et al., 2010 Timbremont, & Braet, 2004; Garcia et al., 2010). Inclusion of 
quantitative parental report of additional symptoms at admission and discharge might serve as 
evidence of therapeutic progress for the patient as well as important information for follow-up 
providers on rate of change.    
OCD symptom severity. Consistent with the literature, OCD symptom severity 
demonstrated the greatest predictability of treatment outcome in the current study.  Both 
obsessions and compulsions alone significantly predicted OCD severity at discharge.  The 
predictive validity of all four models to investigate severity at discharge only ranged from 3.2% 
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to 9.9%, but interestingly the compulsion subtest alone predicted as well as both subtests 
together and the composite CY-BOCS-SR score alone.  Given that the compulsions subtest 
explained only 9.9% of the variance in discharge composite CY-BOCS-SR scores, this finding is 
small but may be worth further investigation.  While OCD symptom severity has consistently 
been found to significantly predict overall impairment in pediatric populations (Piacentini et al., 
2003; Piacentini, Peris, Bergman, Chang, & Jaffer, 2007; Storch et al., 2010; Valderhaug, & 
Ivarsson, 2005) it is unclear as to the specificity of functional impairment in the current patient 
sample.  In contrast to the current findings, Piacentini et al. (2002) found that more severe 
obsessions, not compulsions, were related to poorer treatment outcomes.  In the same sample, 
however, academic impairments were also significantly associated with poor outcome offering a 
specific area of functionality impacted.  It is likely that increased obsessional severity may also 
be related to poor school performance due to the degree of concentration needed to succeed 
academically.  This begs the question of what differences exist between outpatients with 
moderate to severe OCD symptoms and patients receiving intensive residential treatment with 
the same range of reported severity.  Perhaps patients receiving care on an outpatient basis are 
in an earlier stage of OCD onset whereas patients seeking residential treatment have been fully 
engulfed in compulsions, which consequently impact overall functioning. 
OCD symptom subtype.  OCD symptom presentation was not found to significantly 
predict treatment outcome in the current investigation.  There is some support for the 
combination of factors as being predictive in that they explained approximately 12% of the 
variance in CY-BOCS-SR scores at discharge, higher than all other models including symptom 
severity; however, they were found to be non-significant.  Individuals with symmetry, ordering, 
repeating, and checking symptoms (SORC) had a negative relationship with CY-BOCS-SR 
outcome scores as did individuals with symptoms of hoarding (H).  Not surprising, symptoms of 
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hoarding made the strongest unique contribution in explaining treatment outcome as hoarding 
has been linked to poorer outcomes historically (Abramowitz, Franklin, Schwartz, & Furr, 2003; 
Bloch et al., 2009; Masi et al., 2005).  It was surprising that the symptom cluster contamination, 
cleaning, and aggressive/somatic symptoms (CCAS) did not show greater predictability of 
outcomes as it has generally been found to respond the best to treatment (Abramowitz et al., 
2003).   
Strengths and Weaknesses of Research Design 
This was an intent-to-treat sample so only patients who completed the measures of 
interest at admission and had discharge CY-BOCS-SR scores were included in the sample.  
Additionally, only patients with a CY-BOCS-SR score of 16 or above (to indicate moderate 
severity) were included in the study.  Individuals were not excluded based on medication history, 
psychiatric co-morbidity, duration of treatment, response to treatment, or circumstances of 
discharge (i.e. insurance denial, treatment refusal, etc.).   Patient reporting may have been 
influenced by a desire to emphasize the need for treatment at admission by over reporting, a 
lack of insight which led to underreporting, or ambivalence about the treatment stay which also 
impacted scores.  Self-report CY-BOCS scores have been found to be a valid measure of OCD 
severity when compared to interviewer-rated CY-BOCS.  Conelea, Schmidt, Leonard, & Riemann 
(2010) found pediatric patients actually tended to slightly under report symptoms on the CY-
BOCS-SR.   Future research may wish to include parent report (CY-BOCS-PR) when psychometric 
properties are well established (Storch et al., 2006).  Additionally, it may be useful to 
supplement the CY-BOCS-SR with other measures assessing OCD specific symptoms and 
impairments including quality of life and academic, social, and family functioning (e.g. Storch et 
al., 2010b).   
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The present study has several limitations.  First, the determination of OCD as the 
primary diagnoses for the purposes of this study was not systematically determined using a 
structured clinical interview.  Diagnoses were based on information from referents, pre-
admission screenings that included the CY-BOCS-SR Severity Scale and Symptom Checklist, and 
admissions interviews that were conducted by an experienced board-certified child and 
adolescent psychiatrist and were later reviewed by a clinical psychologist with extensive 
expertise in the assessment and treatment of pediatric OCD.   
Second, this sample was drawn from a residential-based clinical setting (the only one of 
its kind) representing a subgroup of particularly impaired patients in terms of clinical severity 
and comorbid presentation.  One benefit from the investigation of predictors within a 
residential setting is the controlled nature of treatment delivery and environmental influences 
when compared to outpatient studies.   This information, while lacking in external validity due to 
the scarcity of such programs, has some internal validity and clinical utility for this specific 
population.  Thus, the generalizability of the study findings and conclusions of this study may be 
limited to the population of patients served by this present treatment program.   
Most patients included in the study were prescribed psychotropic medications for 
primary OCD or co-occurring conditions as part of their treatment.  Medication type, dosage, or 
changes throughout treatment were not included in this study therefore knowledge of the 
impact on treatment outcome is unknown.  Historically, as described above, medications alone 
have not been found to contribute to symptom reduction, especially in severe cases of OCD, as 
well as a combined method of treatment (Franklin et al., 2011).  Additionally, all patients were 
prescribed approximately 26.5 hours of ERP per week in addition to group, individual 
psychotherapy, and experiential therapies totaling upwards of 45 hours of intensive treatment 
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weekly.  It is difficult to partial out factors such as patient adherence to protocols of ERP as well 
as the impact of other less-structured but impactful program components.   
It is possible that the absence of reliable predictors for OCD treatment outcome may 
have been limited by the number of variables initially examined. Factors noted in the literature, 
like family accommodation and psychiatric illness (Merlo, Lehmkuhl, Geffken, & Storch, 2009; 
Storch et al., 2007), patient insight, psychiatric comorbidity, Pediatric Autoimmune 
Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS), cognitive and 
developmental issues (Storch et al., 2010a), and overall functional impairments were not 
included as these types of information were not collected at the site of interest.  Investigating of 
each of these potentially contributing factors was outside the realm of this study due to the 
retroactive nature of the data utilized, but provides direction to follow-up research that would 
be a valuable contribution to the literature.  Few studies have reported quantitative impact of 
these issues on treatment of pediatric OCD and to this writer’s knowledge no evidence exists as 
to the implications of these commonly occurring issues on intensive treatment for OCD with 
adolescents.    
Finally, while the results from the study are informative, it is important to exercise 
caution in interpreting the unique predictive value of certain factors as variables do not operate 
in isolation but rather interact with other variables impacting treatment response.  Perhaps 
gender was a moderating variable of outcome. Females in this sample reported significantly 
higher scores on measures of comorbid symptoms so the relation between comorbid symptoms 
and OCD severity at discharge could be greater for females than males (e.g.,  Maher et al., 2010).  
Previous treatment type might be a mediator variable of outcome in that patients who have 
failed previous treatment may experience increased symptoms of depression which impact their 
success in residential treatment.   Future research should examine moderators, meditational 
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factors, and interactions of pertinent factors for the population of interest as it is likely complex 
relationships exist between biopsychosocial characteristics and impact response to treatment.  
Summary and Conclusion 
The complex nature of the program investigated and complexities of the patients served 
make prediction of treatment outcome a challenge.  Despite difficulty in isolating predictive 
factors to treatment outcome in this sample, 64% of patients in similar samples receiving 
treatment in residential settings have demonstrated clinically significant improvements of OCD 
symptoms (Leonard et al., 2014).  ERP paired with psychopharmacological interventions 
continues to be the gold standard of treatment for pediatric OCD and is supported in the 
literature.  It is possible that for patients with OCD, and other comorbid symptoms which 
constitute residential treatment, ERP may be the single most contributing factor to treatment 
success.  The additional program components could provide patients with qualitative 
psychological or behavioral improvements that increase their availability for ERP treatment.  
Due to the enumerable factors (peer relationships, therapeutic rapport, isolation of individual 
from family dynamics, etc.) and various program components (individual, group, experiential 
therapy, etc.) it is difficult to determine how much ERP contributes to treatment outcome in this 
residential setting without a systematic investigation with controlled groups.  The challenge 
remains to systematically identify program components that match unique patient needs to 
increase prescriptive efficacy with this difficult-to-treat population.  
In summary, the findings from the current study contribute to the literature on OCD 
treatment outcomes investigating whether and how various factors predict outcomes for 
adolescent patients with OCD receiving CBT treatment in a residential setting. The current 
investigation revealed the difficulty of predicting treatment outcome within a complex 
treatment modality with a heterogeneous patient population but also set the stage for further 
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inquiry.  The difference found among subtests on the CY-BOCS-SR in predicting treatment 
outcome provides evidence for the need for additional investigations of the link between 
severity of compulsory behaviors at admission and response to treatment.   Additionally, studies 
of the relation between treatment history and outcome deserve additional exploration to 
uncover factors related to type of treatment received prior to admission and treatment 
response.  Better understanding of the predictors of treatment outcome for this unique 
population should lead to further investigation of effective and targeted treatment techniques. 
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